PRESS RELEASE

Q3 2021 — Press release

Q3 2021PDF · 48 pages1.0 MB
PRESS RELEASE
Investor Relations: Media:
New York: +1 (917) 663 2233 Lausanne: +41 (0)58 242 4500
Lausanne: +41 (0)58 242 4666 Email: Iro.Antoniadou@pmi.com
Email: InvestorRelations@pmi.com
PHILIP MORRIS INTERNATIONAL INC. REPORTS 2021 THIRD-QUARTER
REPORTED DILUTED EPS OF $1.55 AND ADJUSTED DILUTED EPS OF $1.58, REPRESENTING
CURRENCY-NEUTRAL GROWTH OF 8.5%;
REVISES AND NARROWS 2021 FULL-YEAR REPORTED DILUTED EPS FORECAST
TO A RANGE OF $5.77 TO $5.82, OR $6.01 TO $6.06 ON AN ADJUSTED BASIS, REPRESENTING
CURRENCY-NEUTRAL GROWTH OF 13% TO 14%
NEW YORK, October 19, 2021 – Philip Morris International Inc. (NYSE: PM) today announces its 2021 third-
quarter results. Growth rates presented in this press release on an organic basis reflect currency-neutral
underlying results. Adjusted net revenues exclude the impact related to the Saudi Arabia customs assessments.
A glossary of key terms, definitions and explanatory notes is included at the end of this press release.
Adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures are
included in the schedules to this press release.
2021 THIRD-QUARTER & YEAR-TO-DATE HIGHLIGHTS
2021 Third-Quarter
• Reported diluted EPS of $1.55, up by 4.7%; up by 2.0%, excluding currency
• Adjusted diluted EPS of $1.58, up by 11.3%; up by 8.5%, excluding currency
• Cigarette and heated tobacco unit shipment volume up by 2.1% (reflecting cigarette shipment volume down
by 0.4%, and heated tobacco unit shipment volume up by 23.8% to 23.5 billion units)
• Market share for heated tobacco units in IQOS markets, excluding the U.S., up by 1.2 points to 6.8%
• Net revenues up by 9.1%; up by 7.6%, on an organic basis
• Net revenues from smoke-free products accounted for 28.6% of total net revenues
• Operating income up by 6.5%; up by 4.5%, excluding currency
• Adjusted operating income up by 7.4% on an organic basis
• Adjusted operating income margin up by 0.1 point; down by 0.1 point on an organic basis
• Total IQOS users at quarter-end estimated at approximately 20.4 million, of which approximately 14.9 million
have switched to IQOS and stopped smoking
• Increased its regular quarterly dividend by 4.2% to an annualized rate of $5.00 per common share
• Repurchased 0.9 million shares of its common stock for $94 million, at an average price of $98.99 per share

-- 1 of 48 --

2021 Nine Months Year-to-Date
• Reported diluted EPS of $4.48, up by 14.9%; up by 10.3%, excluding currency
• Adjusted diluted EPS of $4.72, up by 20.4%; up by 15.8% excluding currency
• Cigarette and heated tobacco unit shipment volume up by 1.5% (reflecting cigarette shipment volume down
by 1.6%, and heated tobacco unit shipment volume up by 27.9% to 69.6 billion units)
• Market share for heated tobacco units in IQOS markets, excluding the U.S., up by 1.3 points to 6.9%
• Net revenues up by 9.7%; up by 6.1% excluding currency
• Adjusted net revenues up by 7.3% on an organic basis
• Net revenues from smoke-free products accounted for 28.6% of total adjusted net revenues
• Operating income up by 14.4%; up by 10.1%, excluding currency
• Adjusted operating income up by 14.5% on an organic basis
• Adjusted operating income margin up by 3.0 points; up by 2.8 points on an organic basis
"Our business delivered another strong quarterly performance, coming ahead of our expectations with adjusted
diluted EPS of $1.58, representing growth of 8.5%, excluding currency," said Jacek Olczak, Chief Executive
Officer.
"The continued excellent performance of IQOS drove total shipment volume and organic net revenue growth of
2.1% and 7.6%, respectively, and was complemented by further sequential share gains for our combustible
products."
"Today, we are reaffirming our strong growth outlook for 2021, with an adjusted diluted EPS forecast toward the
upper-half of our previous range and representing currency-neutral growth of 13% to 14%, despite ongoing
tightness in device supplies due to the global shortage of semiconductors, which impacts our ability to fulfill
consumer demand for IQOS."
"We confirm our confidence in our 2021 to 2023 growth targets, despite device constraints that could persist into
the first half of 2022, with temporarily lower IQOS user growth rates."
- 2 -

-- 2 of 48 --

2021 FULL-YEAR FORECAST
Full-Year
2021
Forecast 2020 Growth
Reported Diluted EPS $5.77 - $5.82 $ 5.16
Saudi Arabia customs assessments 0.14 —
Asset impairment and exit costs 0.09 0.08
Asset acquisition cost 0.03 —
Equity investee ownership dilution (0.02) —
Fair value adjustment for equity security investments 0.04
Tax items (0.06)
Brazil indirect tax credit (0.05)
Adjusted Diluted EPS $6.01 - $6.06 $ 5.17
Currency (0.17)
Adjusted Diluted EPS, excluding currency $5.84 - $5.89 $ 5.17 13% - 14%
PMI revises and narrows its full-year reported diluted EPS forecast to a range of $5.77 to $5.82, at prevailing
exchange rates, from a range of $5.76 to $5.86 previously, primarily reflecting:
• Asset impairment and exit costs of $0.09 per share, compared to $0.07 per share previously, due to
organizational design optimization and product distribution restructuring in South Korea;
• Asset acquisition cost of $0.03 per share, due to a $51 million pre-tax charge related to the purchase of
OtiTopic (see related discussion under "Other" on page 28);
• A favorable impact related to equity ownership dilution in Medicago, Inc. of $0.02 per share, following PMI's
ownership reduction in July 2021 to approximately 25%, from approximately 32% previously; and
• A favorable currency impact of $0.17 at prevailing exchange rates, compared to $0.18 per share, previously.
This forecast represents a projected currency-neutral increase in adjusted diluted EPS of around 13% to 14%
versus adjusted diluted EPS of $5.17 in 2020, as outlined in the table above.
2021 Full-Year Forecast Assumptions
This forecast assumes:
• A continued gradual improvement in the general operating environment, with potential volatility around the
duration and effects of pandemic-related mobility restrictions across PMI's key markets;
• Constrained IQOS device supply due to the ongoing global semiconductor shortage, with reduced device
assortment and availability, and therefore lower IQOS user growth rates as PMI prioritizes devices for
existing IQOS users; 2021 ILUMA launches in certain markets now planned for the second half of 2022;
• A slight recovery in PMI's duty-free business during the fourth quarter, following a modest improvement in
the third quarter, with intercontinental and Asia travel still very subdued;
• An estimated total international industry volume progression, excluding China and the U.S., of approximately
flat to +1%, compared to approximately -1% to +1%, previously;
• A total cigarette and heated tobacco unit shipment volume increase for PMI of approximately 1% to 2%,
compared to a progression of approximately flat to +2%, previously;
• Heated tobacco unit shipment volume of around 95 billion units;
- 3 -

-- 3 of 48 --

• Adjusted net revenue growth of approximately 6.5% to 7% on an organic basis, compared to a range of 6%
to 7%, previously;
• An increase in adjusted operating income margin of around 200 basis points on an organic basis;
• Incremental commercial investments in the second half of 2021 of approximately $300 million versus the first
half, compared to a range of approximately $300 to $400 million, previously;
• Operating cash flow of around $11 billion at prevailing exchange rates and subject to year-end working
capital requirements;
• Capital expenditures of approximately $0.6 billion, compared to approximately $0.8 billion, previously;
• An effective tax rate, excluding discrete tax events, of around 22%;
• No material impact of any share repurchases; and
• No material impact related to the acquisitions of Fertin Pharma A/S or Vectura Group plc.
The foregoing is underpinned by the assumption that, even in the event of prolonged pandemic-related
restrictions, there will not be a return to the depressed consumption levels of the second quarter of 2020. This
assumption is consistent with the less severe impact on consumption levels observed in the second half of 2020
as COVID-19 spread in a number of markets.
This forecast excludes the impact of any future acquisitions, unanticipated or unquantifiable asset impairment
and exit cost charges, future changes in currency exchange rates, further developments pertaining to the
judgment in the two Québec Class Action lawsuits and the Companies’ Creditors Arrangement Act (CCAA)
protection granted to PMI's Canadian subsidiary, Rothmans, Benson & Hedges, Inc. (RBH), any unusual events,
any intensification of the global shortage of semiconductors and the related impact on the supply of our
electronic devices, and any COVID-19-related developments different from the assumptions set forth in the
company's forecast.
Factors described in the Forward-Looking and Cautionary Statements section of this release represent
continuing risks to these projections.
IQOS Device Supply
As communicated in September, the global semiconductor shortage is resulting in a tightness in IQOS device
supply. This is affecting the availability and assortment of IQOS devices in certain markets, which is hampering
the company’s ability to operate at full commercial and competitive capacity to fully meet demand. This has been
reflected in lower IQOS user growth rates in the third quarter.
At this stage, supply forecasting remains volatile. PMI therefore assumes that the tight supply situation will
persist into the first half of 2022 and, where necessary, the company will prioritize device replacements for
existing IQOS users over device sales targeting user acquisition. PMI is also adjusting its launch timeline for
IQOS ILUMA outside Japan, with additional major launches now assumed for the second half of 2022.
PMI views this as a temporary phenomenon and expects IQOS user growth to re-accelerate once shortages
ease, as consumer demand remains robust. PMI confirms its confidence in its 2021 to 2023 organic compound
annual growth targets for net revenues and adjusted diluted EPS (more than 5% and 9%, respectively), though
there are short-term shortage scenarios under which the transitory IQOS device supply impact on user growth
could result in full-year 2022 organic growth rates below the company's 2021 to 2023 growth targets.
- 4 -

-- 4 of 48 --

Acquisitions
On August 9, 2021, PMI acquired 100% of OtiTopic, Inc., a U.S. respiratory drug development company with a
late-stage dry powder inhalation aspirin treatment for acute myocardial infarction. The cost of the acquisition was
$51 million, excluding potential additional contingent payments related to the achievement of certain milestones.
On September 15, 2021, PMI acquired 100% of Fertin Pharma A/S, a Danish company that is a leading
developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral
delivery systems, for a total consideration of DKK 5.2 billion (approximately $820 million).
As of September 30, 2021, PMI held a 96.86% controlling interest in Vectura Group plc (Vectura), an inhaled
therapeutics company based in the United Kingdom, following a series of purchases of Vectura shares and valid
acceptances of PMI's offer at a price of 165 pence per share. The delisting and cancellation of trading of Vectura
shares was effective as of today. PMI intends to exercise its right to compulsorily acquire the remaining shares of
Vectura, in accordance with applicable English law.
Conference Call
A conference call, hosted by Emmanuel Babeau, Chief Financial Officer, will be webcast at 9:00 a.m., Eastern
Time, on October 19, 2021. Access is at www.pmi.com/2021Q3earnings.
CONSOLIDATED SHIPMENT VOLUME & MARKET SHARE
PMI Shipment Volume by Region Third-Quarter Nine Months Year-to-Date
(million units) 2021 2020 Change 2021 2020 Change
Cigarettes
European Union 41,965 45,179 (7.1) % 120,238 126,142 (4.7) %
Eastern Europe 25,020 25,661 (2.5) % 67,771 70,737 (4.2) %
Middle East & Africa 35,166 30,903 13.8 % 93,155 88,087 5.8 %
South & Southeast Asia 35,578 37,238 (4.5) % 105,787 108,179 (2.2) %
East Asia & Australia 11,120 10,784 3.1 % 33,450 35,154 (4.8) %
Americas 15,994 15,699 1.9 % 46,092 45,542 1.2 %
Total PMI 164,843 165,464 (0.4) % 466,493 473,841 (1.6) %
Heated Tobacco Units
European Union 7,058 5,181 36.2 % 20,405 14,069 45.0 %
Eastern Europe 6,119 4,882 25.3 % 18,594 14,374 29.4 %
Middle East & Africa 577 179 +100% 1,485 834 78.1 %
South & Southeast Asia 79 10 +100% 151 10 +100%
East Asia & Australia 9,435 8,601 9.7 % 28,478 24,799 14.8 %
Americas 221 114 93.9 % 466 316 47.5 %
Total PMI 23,489 18,967 23.8 % 69,579 54,402 27.9 %
Cigarettes and Heated Tobacco Units
European Union 49,023 50,360 (2.7) % 140,643 140,211 0.3 %
Eastern Europe 31,139 30,543 2.0 % 86,365 85,111 1.5 %
Middle East & Africa 35,743 31,082 15.0 % 94,640 88,921 6.4 %
South & Southeast Asia 35,657 37,248 (4.3) % 105,938 108,189 (2.1) %
East Asia & Australia 20,555 19,385 6.0 % 61,928 59,953 3.3 %
Americas 16,215 15,813 2.5 % 46,558 45,858 1.5 %
Total PMI 188,332 184,431 2.1 % 536,072 528,243 1.5 %
- 5 -

-- 5 of 48 --

Third-Quarter
PMI's total shipment volume increased by 2.1%, driven by:
• Eastern Europe, reflecting higher heated tobacco unit shipment volume across the Region, primarily in
Russia and Ukraine, partly offset by lower cigarette shipment volume, mainly in Russia and Ukraine;
• Middle East & Africa, mainly reflecting higher cigarette shipment volume, primarily in PMI Duty Free and
Turkey, partly offset by North Africa (particularly Egypt);
• East Asia & Australia, reflecting higher heated tobacco unit shipment volume, primarily in Japan, and higher
cigarette shipment volume, mainly in Japan, partly offset by Australia and South Korea; and
• Americas, mainly reflecting higher cigarette shipment volume, notably in Mexico;
partly offset by
• the EU, reflecting lower cigarette shipment volume, mainly in France, Italy and Spain, partly offset by higher
heated tobacco unit shipment volume across the Region, notably in Italy; and
• South & Southeast Asia, primarily reflecting lower cigarette shipment volume, mainly in the Philippines, partly
offset by Indonesia.
Impact of Inventory Movements
Excluding the net favorable impact of estimated distributor inventory movements of approximately 2.8 billion
units, PMI’s total in-market sales increased by 0.6%, driven by a 20.2% increase in heated tobacco units, partly
offset by a 1.8% decrease in cigarettes.
The net favorable impact of approximately 2.8 billion units reflected:
• A net favorable impact of 2.4 billion cigarettes, mainly driven by 2020 movements in Japan and PMI Duty
Free; and
• A net favorable impact of 0.4 billion heated tobacco units, notably reflecting 2020 movements in PMI Duty
Free.
PMI's total heated tobacco unit in-market sales volume in the quarter was 24.6 billion units, reflecting sequential
growth of 7.2% compared to the second quarter of 2021.
Nine Months Year-to-Date
PMI's total shipment volume increased by 1.5%, driven by:
• the EU, reflecting higher heated tobacco unit shipment volume across the Region, particularly in Germany,
Hungary, Italy and Poland, partly offset by lower cigarette shipment volume, notably in the Czech Republic,
France, Germany and Hungary;
• Eastern Europe, reflecting higher heated tobacco unit shipment volume, primarily in Russia and Ukraine,
partly offset by lower cigarette shipment volume, mainly in Russia and Ukraine;
• Middle East & Africa, reflecting higher cigarette shipment volume (primarily in PMI Duty Free and Turkey,
partly offset by North Africa), as well as higher heated tobacco unit shipment volume across the Region;
• East Asia & Australia, reflecting higher heated tobacco unit shipment volume driven by Japan, partly offset
by lower cigarette shipment volume, predominantly in Japan and South Korea; and
- 6 -

-- 6 of 48 --

• Americas, mainly reflecting higher cigarette shipment volume, primarily in Brazil and Mexico, partially offset
by Argentina;
partly offset by
• South & Southeast Asia, primarily reflecting lower cigarette shipment volume, mainly in the Philippines,
partially offset by Indonesia and Pakistan.
Impact of Inventory Movements
Excluding the net favorable impact of estimated distributor inventory movements of approximately 5.0 billion
units, PMI’s total in-market sales increased by 0.5%, driven by a 23.3% increase in heated tobacco units, partly
offset by a 2.1% decrease in cigarettes.
The net favorable impact of approximately 5.0 billion units reflected:
• A net favorable impact of 2.8 billion cigarettes, mainly driven by 2020 movements in Japan, PMI Duty Free
and Russia; and
• A net favorable impact of 2.2 billion heated tobacco units, primarily driven by 2020 movements in Japan.
PMI's total heated tobacco unit in-market sales volume in the nine months year-to-date was 68.8 billion units.
PMI Shipment Volume by Brand
PMI Shipment Volume by Brand Third-Quarter Nine Months Year-to-Date
(million units) 2021 2020 Change 2021 2020 Change
Cigarettes
Marlboro 65,139 61,581 5.8 % 177,287 175,638 0.9 %
L&M 21,564 24,189 (10.9) % 64,028 69,215 (7.5) %
Chesterfield 15,994 13,768 16.2 % 43,021 39,274 9.5 %
Philip Morris 11,107 12,254 (9.4) % 31,881 34,823 (8.4) %
Parliament 11,556 9,540 21.1 % 30,535 25,575 19.4 %
Sampoerna A 9,717 7,999 21.5 % 27,601 23,801 16.0 %
Dji Sam Soe 5,518 6,372 (13.4) % 16,644 18,344 (9.3) %
Bond Street 3,042 6,441 (52.8) % 12,200 18,481 (34.0) %
Lark 4,070 3,846 5.8 % 11,851 12,059 (1.7) %
Next 2,388 2,327 2.7 % 6,556 6,703 (2.2) %
Others 14,748 17,147 (14.0) % 44,889 49,928 (10.1) %
Total Cigarettes 164,843 165,464 (0.4) % 466,493 473,841 (1.6) %
Heated Tobacco Units 23,489 18,967 23.8 % 69,579 54,402 27.9 %
Total PMI 188,332 184,431 2.1 % 536,072 528,243 1.5 %
Note: Lark includes Lark Harmony; Next includes Next Dubliss; Philip Morris includes Philip Morris/Dubliss; and Sampoerna A includes
Sampoerna.
Third-Quarter
The increase in PMI's heated tobacco unit shipment volume was mainly driven by the EU (notably Italy), Eastern
Europe (notably Russia) and Japan.
PMI's cigarette shipment volume of the following brands increased:
• Marlboro, mainly driven by PMI Duty Free, Russia and Turkey, partly offset by Italy and the Philippines;
• Chesterfield, primarily driven by Russia;
• Parliament, mainly driven by Saudi Arabia and Turkey;
- 7 -

-- 7 of 48 --

• Sampoerna A in Indonesia, primarily driven by premium A Mild;
• Lark, mainly driven by Japan; and
• Next, primarily driven by Russia.
PMI's cigarette shipment volume of the following brands decreased:
• L&M, primarily due to Egypt, Poland, Russia, Spain, Thailand and Turkey;
• Philip Morris, mainly due to Russia, partly offset by Japan;
• Dji Sam Soe in Indonesia, primarily due to Dji Sam Soe Magnum Mild;
• Bond Street, mainly due to Russia; and
• "Others," primarily due to: mid-price Fortune (Philippines) and Sampoerna U (Indonesia).
International Share of Market
PMI's total international market share (excluding China and the U.S.), defined as PMI's cigarette and heated
tobacco unit sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, was
flat at 28.0%, reflecting:
• Total international market share for heated tobacco units of 3.6%, up by 0.6 points; and
• Total international market share for cigarettes of 24.4%, down by 0.6 points.
PMI's total international cigarette sales volume as a percentage of total industry cigarette sales volume was
down by 0.4 points to 25.6%, mainly reflecting lower cigarette market share and/or an unfavorable geographic
mix impact, notably in Egypt, France, Japan, the Philippines, Russia and Ukraine, partly offset by Indonesia, PMI
Duty-Free and Turkey.
Nine Months Year-to-Date
The increase in PMI's heated tobacco unit shipment volume was mainly driven by the EU (notably Italy), Eastern
Europe (notably Russia and Ukraine) and Japan.
PMI's cigarette shipment volume of the following brands increased:
• Marlboro, mainly driven by Mexico, PMI Duty Free, Russia and Turkey, partly offset by France, the GCC,
Japan and the Philippines;
• Chesterfield, primarily driven by Brazil, the Philippines and Russia, partly offset by Saudi Arabia;
• Parliament, mainly driven by Russia, Saudi Arabia and Turkey, partly offset by Japan and South Korea; and
• Sampoerna A in Indonesia, primarily driven by premium A Mild.
PMI's cigarette shipment volume of the following brands decreased:
• L&M, mainly due to Egypt, Germany, Poland, Russia and Turkey;
• Philip Morris, primarily due to Indonesia, Italy and Russia, partly offset by Japan;
• Dji Sam Soe in Indonesia, mainly due to Dji Sam Soe Magnum Mild;
• Bond Street, primarily due to Kazakhstan, Russia and Ukraine;
• Lark, mainly due to Japan;
• Next, primarily due to Canada and Ukraine, partly offset by Russia; and
• "Others," notably due to: mid-price Fortune (Philippines) and Sampoerna U (Indonesia); and low-price
Jackpot (Philippines) and More (Philippines); partly offset by mid-price Sampoerna Hijau (Indonesia) and
low-price Morven (Pakistan).
- 8 -

-- 8 of 48 --

International Share of Market
PMI's total international market share (excluding China and the U.S.) decreased by 0.6 points to 27.3%,
reflecting:
• Total international market share for cigarettes of 23.8%, down by 1.1 points; and
• Total international market share for heated tobacco units of 3.5%, up by 0.6 points.
PMI's total international cigarette sales volume as a percentage of total industry cigarette sales volume was
down by 0.9 points to 24.9%, mainly reflecting lower cigarette market share and/or an unfavorable geographic
mix impact, notably in Japan, the Philippines, Russia and Ukraine, partly offset by Indonesia and Turkey.
CONSOLIDATED FINANCIAL SUMMARY
Third-Quarter
Financial Summary -
Quarters Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 8,122 $ 7,446 9.1 % 7.6 % 676 107 2 158 439 (30)
Cost of Sales (2,596) (2,416) (7.5) % (5.8) % (180) (40) (1) — (211) 72
Marketing,
Administration and
Research Costs (2,053) (1,769) (16.1) % (15.9) % (284) (2) (1) — — (281)
Amortization of
Intangibles (18) (18) — % — % — — — — — —
Operating Income $ 3,455 $ 3,243 6.5 % 4.5 % 212 65 — 158 228 (239)
Asset Impairment & Exit
Costs (1) (43) — — % — % (43) — — — — (43)
Asset Acquisition Cost (1) (51) — — % — % (51) — — — — (51)
Adjusted Operating
Income $ 3,549 $ 3,243 9.4 % 7.4 % 306 65 — 158 228 (145)
Adjusted Operating
Income Margin 43.7 % 43.6 % 0.1pp (0.1) pp
(1) Included in Marketing, Administration and Research Costs above.
Net revenues increased by 7.6% on an organic basis, mainly reflecting: favorable volume/mix, primarily driven by
higher heated tobacco unit volume (notably in the EU, particularly Germany, Italy and Poland, as well as Japan,
PMI Duty Free and Russia) and higher device volume (primarily in Japan, driven by the launch of IQOS ILUMA),
partly offset by lower cigarette volume (mainly in Australia, France, Germany, Italy and the Philippines, partly
offset by Indonesia, Japan, PMI Duty Free and Turkey) and unfavorable cigarette mix (mainly in Germany, Japan
and Russia); and a favorable pricing variance (notably driven by Japan, the Philippines, Russia and Turkey,
partly offset by Indonesia, Poland and Ukraine).
Operating income increased by 4.5%, excluding currency, primarily reflecting: favorable volume/mix, primarily
driven by higher heated tobacco unit volume, partly offset by lower cigarette volume and unfavorable cigarette
mix (each mainly reflecting the same geographies as for net revenues noted above); a favorable pricing
variance; and lower manufacturing costs (driven by productivity gains related to reduced-risk products); partly
offset by higher marketing, administration and research costs (due mainly to investments behind reduced-risk
products, asset acquisition costs related to OtiTopic, and higher asset impairment and exit costs due to
- 9 -

-- 9 of 48 --

organizational design optimization and product distribution restructuring in South Korea).
Adjusted operating income increased by 7.4% on an organic basis. Adjusted operating income margin
decreased by 0.1 point on the same basis, as detailed in Schedule 8.
Nine Months Year-to-Date
Financial Summary -
Nine Months Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 23,301 $ 21,250 9.7 % 6.1 % 2,051 752 2 590 983 (276)
Saudi Arabia Customs
Assessments (246) — — % — % (246) — — — — (246)
Adjusted Net Revenues $ 23,547 $ 21,250 10.8 % 7.3 % 2,297 752 2 590 983 (30)
Net Revenues (1) $ 23,301 $ 21,250 9.7 % 6.1 % 2,051 752 2 590 983 (276)
Cost of Sales (7,223) (6,997) (3.2) % 0.5 % (226) (260) (1) — (329) 364
Marketing,
Administration and
Research Costs (5,995) (5,435) (10.3) % (8.2) % (560) (112) (1) — — (447)
Amortization of
Intangibles (55) (55) — % 1.8 % — (1) — — — 1
Operating Income $ 10,028 $ 8,763 14.4 % 10.1 % 1,265 379 — 590 654 (358)
Asset Impairment & Exit
Costs (2) (170) (71) -(100)% -(100)% (99) — — — — (99)
Saudi Arabia Customs
Assessments (3) (246) — — % — % (246) — — — — (246)
Asset Acquisition Cost (2) (51) — — % — % (51) — — — — (51)
Adjusted Operating
Income $ 10,495 $ 8,834 18.8 % 14.5 % 1,661 379 — 590 654 38
Adjusted Operating
Income Margin 44.6 % 41.6 % 3.0pp 2.8pp
(1) Cost/Other variance includes a reduction in net revenues of $246 million in 2021 related to the Saudi Arabia customs assessments.
(2) Included in Marketing, Administration and Research Costs above.
(3) Included in Net Revenues above.
Net revenues increased by 6.1%, excluding currency, mainly reflecting: favorable volume/mix, primarily driven by
higher heated tobacco unit volume (notably in the EU, particularly Germany, Hungary, Italy and Poland, as well
as Japan and Russia), partly offset by lower cigarette volume (mainly in the EU Region, notably the Czech
Republic, France and Germany, as well as Japan, Kuwait, North Africa, the Philippines, Russia and Ukraine,
partially offset by Indonesia, PMI Duty Free, and Turkey); and a favorable pricing variance (notably driven by the
Czech Republic, Germany, Japan, Kazakhstan, North Africa, the Philippines, Russia and Turkey, partly offset by
Indonesia, Poland and Ukraine); partially offset by the unfavorable impact of the Saudi Arabia customs
assessments of $246 million, shown in "Cost/Other". Adjusted net revenues increased by 7.3% on an organic
basis, as detailed above and in Schedule 5.
Operating income increased by 10.1%, excluding currency, primarily reflecting: favorable volume/mix, mainly
driven by the same factors as for net revenues noted above; a favorable pricing variance; and lower
- 10 -

-- 10 of 48 --

manufacturing costs (driven by productivity gains related to reduced-risk and combustible products); partly offset
by the unfavorable impact of the Saudi Arabia customs assessments (as noted above for net revenues); and
higher marketing, administration and research costs, including higher asset impairment and exit costs (mainly
related to organizational design optimization, as well as product distribution restructuring in South Korea) and
asset acquisition costs related to OtiTopic.
Adjusted operating income increased by 14.5% on an organic basis. Adjusted operating income margin
increased by 2.8 points on the same basis, as detailed in Schedule 8.
EUROPEAN UNION REGION
Third-Quarter
Financial Summary -
Quarters Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 3,192 $ 2,950 8.2 % 3.9 % 242 128 2 (5) 117 —
Operating Income $ 1,680 $ 1,588 5.8 % 0.8 % 92 79 — (5) 102 (84)
Asset Impairment & Exit
Costs (1) (12) — — % — % (12) — — — — (12)
Adjusted Operating
Income $ 1,692 $ 1,588 6.5 % 1.6 % 104 79 — (5) 102 (72)
Adjusted Operating
Income Margin 53.0 % 53.8 % (0.8)pp (1.2)pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues increased by 3.8% on an organic basis, as detailed in Schedule 5, reflecting: favorable volume/
mix, mainly driven by higher heated tobacco unit volume (notably in Germany, Hungary, Italy and Poland), partly
offset by lower cigarette volume (notably in France, Germany and Italy) and unfavorable cigarette mix (primarily
in Germany). Pricing variance was slightly unfavorable, reflecting lower pricing for reduced-risk products (notably
for heated tobacco units in Poland and devices in Germany and Italy), partly offset by higher combustible pricing
(notably in Germany, partially offset by Poland).
Operating income increased by 0.8%, excluding currency, primarily reflecting: favorable volume/mix, driven by
the same factors as for net revenues noted above; and lower manufacturing costs; partly offset by higher
marketing, administration and research costs.
Adjusted operating income increased by 1.6% on an organic basis. Adjusted operating income margin
decreased by 1.1 points on the same basis, as detailed in Schedule 8.
- 11 -

-- 11 of 48 --

Nine Months Year-to-Date
Financial Summary -
Nine Months Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 9,250 $ 7,960 16.2 % 8.0 % 1,290 651 2 67 570 —
Operating Income $ 4,811 $ 3,924 22.6 % 12.1 % 887 413 — 67 507 (100)
Asset Impairment & Exit
Costs (1) (56) (27) -(100)% -(100)% (29) — — — — (29)
Adjusted Operating
Income $ 4,867 $ 3,951 23.2 % 12.7 % 916 413 — 67 507 (71)
Adjusted Operating
Income Margin 52.6 % 49.6 % 3.0pp 2.2pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues increased by 8.0% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher
heated tobacco unit volume (notably in Germany, Hungary, Italy and Poland), partly offset by lower cigarette
volume (notably in the Czech Republic, France and Germany) and unfavorable cigarette mix (primarily in
Germany and Poland); and a favorable pricing variance, driven by higher combustible pricing (mainly in
Germany and Portugal, partly offset by France and Poland) and higher heated tobacco unit pricing (notably in
the Czech Republic, partially offset by Poland), partly offset by lower device pricing (notably in Germany and
Italy).
Operating income increased by 12.1%, excluding currency, primarily reflecting: favorable volume/mix, driven by
the same factors as for net revenues noted above; lower manufacturing costs (driven by combustible and
reduced-risk products); and a favorable pricing variance; partly offset by higher marketing, administration and
research costs (including higher asset impairment and exit costs, mainly related to organizational design
optimization).
Adjusted operating income increased by 12.7% on an organic basis. Adjusted operating income margin
increased by 2.2 points on the same basis, as detailed in Schedule 8.
- 12 -

-- 12 of 48 --

Total Market, PMI Shipment & Market Share Commentaries
European Union Key Data Third-Quarter Nine Months Year-to-Date
Change Change
2021 2020 % / pp 2021 2020 % / pp
Total Market (billion units) 132.4 132.6 (0.1) % 360.5 358.1 0.7 %
PMI Shipment Volume (million units)
Cigarettes 41,965 45,179 (7.1) % 120,238 126,142 (4.7) %
Heated Tobacco Units 7,058 5,181 36.2 % 20,405 14,069 45.0 %
Total EU 49,023 50,360 (2.7) % 140,643 140,211 0.3 %
PMI Market Share
Marlboro 16.5 % 17.5 % (1.0) 16.7 % 17.6 % (0.9)
L&M 5.6 % 6.0 % (0.4) 5.7 % 6.3 % (0.6)
Chesterfield 5.5 % 5.5 % — 5.5 % 5.6 % (0.1)
Philip Morris 2.2 % 2.5 % (0.3) 2.2 % 2.5 % (0.3)
HEETS 5.3 % 3.9 % 1.4 5.5 % 3.9 % 1.6
Others 3.1 % 3.0 % 0.1 3.0 % 3.0 % —
Total EU 38.2 % 38.4 % (0.2) 38.6 % 38.9 % (0.3)
Note: HEETS includes HEETS Dimensions.
Third-Quarter
The estimated total market in the EU decreased by 0.1% to 132.4 billion units, mainly due to:
• Czech Republic, down by 9.0%, primarily reflecting the impact of excise tax-driven price increases; and
• France, down by 8.0%, mainly reflecting the impact of excise tax-driven price increases and higher cross-
border (non-domestic) purchases due to the easing of pandemic-related measures;
partly offset by
• Poland, up by 3.4%, primarily reflecting the impact on adult smoker average daily consumption and border
sales of the easing of pandemic-related measures; and
• Romania, up by 7.1%, mainly reflecting the impact on adult smoker average daily consumption of the easing
of pandemic-related measures, as well as increased in-bound travel.
PMI's total shipment volume decreased by 2.7% to 49.0 billion units, primarily due to:
• Czech Republic, down by 9.5%, mainly reflecting the lower total market;
• France, down by 10.8%, primarily reflecting the lower total market and a lower market share of cigarettes;
• Italy, down by 3.1%. Excluding the net unfavorable impact of estimated distributor inventory movements,
total in-market sales volume increased by 3.6%, reflecting a higher total market and a higher market share
driven by heated tobacco units; and
• Spain, down by 9.1%. Excluding the net unfavorable impact of estimated distributor inventory movements,
total in-market sales volume increased by 3.0%, mainly reflecting a higher total market;
partly offset by
• Poland, up by 3.8%, mainly reflecting the higher total market.
- 13 -

-- 13 of 48 --

Excluding the net unfavorable impact of estimated distributor inventory movements, PMI's total in-market sales
volume decreased by 0.5%.
Nine Months Year-to-Date
The estimated total market in the EU increased by 0.7% to 360.5 billion units, primarily driven by:
• Italy, up by 4.2%, notably reflecting the impact on adult smoker average daily consumption of the easing of
pandemic-related measures; and
• Poland, up by 6.4%, primarily reflecting the impact on adult smoker average daily consumption and border
sales of the easing of pandemic-related measures, as well as a lower prevalence of illicit trade;
partly offset by
• Czech Republic, down by 10.1%, mainly reflecting the impact of excise tax-driven price increases and the
impact, in the first quarter of 2021, of lower border sales due to pandemic-related lockdown measures; and
• France, down by 6.1%, primarily reflecting the same factors as in the quarter.
PMI's total shipment volume increased by 0.3% to 140.6 billion units, primarily driven by:
• Italy, up by 8.1%, mainly reflecting the higher total market and a higher market share driven by heated
tobacco units;
partly offset by
• Czech Republic, down by 12.2%, mainly reflecting the same factor as in the quarter; and
• France, down by 8.3%, mainly reflecting the same factors as in the quarter.
Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales
volume was essentially stable.
EASTERN EUROPE REGION
Third-Quarter
Financial Summary -
Quarters Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 941 $ 899 4.7 % 6.1 % 42 (13) — 22 33 —
Operating Income $ 338 $ 245 38.0 % 25.7 % 93 30 — 22 27 14
Asset Impairment & Exit
Costs (1) (2) — — % — % (2) — — — — (2)
Adjusted Operating
Income $ 340 $ 245 38.8 % 26.5 % 95 30 — 22 27 16
Adjusted Operating
Income Margin 36.1 % 27.3 % 8.8pp 5.2pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues increased by 6.1% on an organic basis, reflecting: favorable volume/mix, driven by higher heated
tobacco unit volume (primarily in Russia and Ukraine), partly offset by unfavorable cigarette volume/mix
(primarily in Russia); and a favorable pricing variance, mainly driven by higher combustible pricing (notably in
Russia), partly offset by lower heated tobacco unit pricing (primarily in Ukraine, partly offset by Russia).
- 14 -

-- 14 of 48 --

Operating income increased by 25.7%, excluding currency, primarily reflecting: favorable volume/mix, driven by
the same factors as for net revenues noted above; a favorable pricing variance; and lower manufacturing costs
(primarily related to reduced-risk products, mainly in Russia).
Adjusted operating income increased by 26.5% on an organic basis. Adjusted operating income margin
increased by 5.2 points on the same basis, as detailed in Schedule 8.
Nine Months Year-to-Date
Financial Summary -
Nine Months Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 2,632 $ 2,470 6.6 % 9.6 % 162 (74) — 68 168 —
Operating Income $ 913 $ 610 49.7 % 50.0 % 303 (2) — 68 140 97
Asset Impairment & Exit
Costs (1) (11) (7) (57.1) % (57.1) % (4) — — — — (4)
Adjusted Operating
Income $ 924 $ 617 49.8 % 50.1 % 307 (2) — 68 140 101
Adjusted Operating
Income Margin 35.1 % 25.0 % 10.1pp 9.2pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues increased by 9.6% on an organic basis, reflecting: favorable volume/mix, driven by higher heated
tobacco unit volume (mainly in Russia and Ukraine), partly offset by unfavorable cigarette volume (primarily in
Russia and Ukraine) and unfavorable cigarette mix (mainly in Russia); and a favorable pricing variance, mainly
driven by higher combustible pricing (primarily in Kazakhstan, Russia and Ukraine), partially offset by lower
device pricing (mainly in Russia) and lower heated tobacco unit pricing (primarily in Ukraine, partly offset by
Russia).
Operating income increased by 50.0%, excluding currency, primarily reflecting: favorable volume/mix, driven by
the same factors as for net revenues noted above; lower manufacturing costs (mainly related to reduced-risk
products, primarily in Russia); and a favorable pricing variance.
Adjusted operating income increased by 50.1% on an organic basis. Adjusted operating income margin
increased by 9.2 points on the same basis, as detailed in Schedule 8.
- 15 -

-- 15 of 48 --

Total Market, PMI Shipment & Market Share Commentaries
PMI Shipment Volume Third-Quarter Nine Months Year-to-Date
(million units) 2021 2020 Change 2021 2020 Change
Cigarettes 25,020 25,661 (2.5) % 67,771 70,737 (4.2) %
Heated Tobacco Units 6,119 4,882 25.3 % 18,594 14,374 29.4 %
Total Eastern Europe 31,139 30,543 2.0 % 86,365 85,111 1.5 %
Third-Quarter
The estimated total market in Eastern Europe decreased, mainly due to:
• Russia, down by 0.9%, or by 2.5% excluding the net favorable impact of estimated trade inventory
movements, primarily reflecting the impact of excise tax-driven price increases and a higher prevalence of
illicit trade; and
• Ukraine, down by 9.6%, mainly reflecting the impact of excise tax-driven price increases and a higher
prevalence of illicit trade.
PMI's total shipment volume increased by 2.0% to 31.1 billion units, notably driven by:
• Russia, up by 0.7%. Excluding the net favorable impact of estimated distributor inventory movements, PMI's
in-market sales decreased by 0.3%, reflecting the lower total market, partly offset by a higher market share
driven by heated tobacco units; and
• Southeast Europe, up by 15.5%, primarily reflecting a higher total market and a higher market share, driven
by heated tobacco units and cigarettes,
partly offset by
• Ukraine, down by 3.2%, mainly reflecting the lower total market, partly offset by a higher market share driven
by heated tobacco units.
Nine Months Year-to-Date
The estimated total market in Eastern Europe decreased, primarily due to:
• Ukraine, down by 9.6%, mainly reflecting the impact of excise tax-driven price increases and a higher
prevalence of illicit trade.
PMI's total shipment volume increased by 1.5% to 86.4 billion units, notably driven by:
• Russia, up by 0.9%. Excluding the net favorable impact of estimated distributor inventory movements, PMI’s
total in-market sales volume was down by 2.1%, mainly reflecting a lower market share (due to cigarettes,
partly offset by heated tobacco units); and
• Southeast Europe, up by 8.0%, primarily reflecting a higher market share (driven by heated tobacco units
and cigarettes) and a higher total market;
partly offset by
• Ukraine, down by 2.0%, mainly reflecting the lower total market, partly offset by a higher market share driven
by heated tobacco units.
- 16 -

-- 16 of 48 --

Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales
volume decreased by 0.5%.
MIDDLE EAST & AFRICA REGION
Third-Quarter
Financial Summary -
Quarters Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 945 $ 768 23.0 % 26.6 % 177 (27) — 64 169 (29)
Operating Income $ 388 $ 261 48.7 % 59.8 % 127 (29) — 64 135 (43)
Asset Impairment & Exit
Costs (1) (3) — — % — % (3) — — — — (3)
Adjusted Operating
Income $ 391 $ 261 49.8 % 60.9 % 130 (29) — 64 135 (40)
Adjusted Operating
Income Margin 41.4 % 34.0 % 7.4pp 9.2pp
(1) Included in Marketing, Administration and Research Costs above.
Net revenues increased by 26.6% on an organic basis, primarily reflecting: favorable volume/mix, mainly driven
by higher cigarette volume (primarily in PMI Duty Free and Turkey, partly offset by North Africa), higher heated
tobacco unit volume (mainly in PMI Duty Free) and favorable cigarette mix (notably in PMI Duty Free); and a
favorable pricing variance, driven by combustible pricing (mainly in Turkey); partly offset by lower fees for certain
distribution rights billed to customers in certain markets, shown in "Cost/Other".
Operating income increased by 59.8%, excluding currency, mainly reflecting: favorable volume/mix, mainly
driven by the same factors as for net revenues noted above; a favorable pricing variance; and lower
manufacturing costs; partly offset by lower fees for certain distribution rights, as noted above for net revenues;
and higher marketing, administration and research costs.
Adjusted operating income increased by 60.9% on an organic basis. Adjusted operating income margin
increased by 9.2 points on the same basis, as detailed in Schedule 8.
- 17 -

-- 17 of 48 --

Nine Months Year-to-Date
Financial Summary -
Nine Months Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 2,306 $ 2,348 (1.8) % 1.0 % (42) (66) — 191 110 (277)
Saudi Arabia Customs
Assessments (246) — — % — % (246) — — — — (246)
Adjusted Net Revenues $ 2,552 $ 2,348 8.7 % 11.5 % 204 (66) — 191 110 (31)
Net Revenues (1) $ 2,306 $ 2,348 (1.8) % 1.0 % (42) (66) — 191 110 (277)
Operating Income $ 739 $ 819 (9.8) % (0.7) % (80) (74) — 191 70 (267)
Asset Impairment & Exit
Costs (2) (13) (9) (44.4) % (44.4) % (4) — — — — (4)
Saudi Arabia Customs
Assessments (3) (246) — — % — % (246) — — — — (246)
Adjusted Operating
Income $ 998 $ 828 20.5 % 29.5 % 170 (74) — 191 70 (17)
Adjusted Operating
Income Margin 39.1 % 35.3 % 3.8pp 5.6pp
(1) Cost/Other variance includes a reduction in net revenues of $246 million in 2021 related to the Saudi Arabia customs assessments.
(2) Included in Marketing, Administration and Research Costs above.
(3) Included in Net Revenues above.
Net revenues increased by 1.0%, excluding currency, despite the unfavorable impact of the Saudi Arabia
customs assessments of $246 million, shown in "Cost/Other".
Adjusted net revenues increased by 11.5% on an organic basis, as detailed above and in Schedule 5, primarily
reflecting: a favorable pricing variance, mainly driven by combustible pricing (mainly in Egypt and Turkey); and
favorable volume/mix, primarily driven by favorable cigarette mix (mainly in PMI Duty Free, Saudi Arabia and
Turkey), higher heated tobacco unit volume (mainly in Egypt, Jordan and PMI Duty Free) and higher cigarette
volume (primarily in PMI Duty Free and Turkey, partly offset by Kuwait and North Africa); partially offset by lower
fees for certain distribution rights billed to customers in certain markets, shown in "Cost/Other".
Operating income decreased by 0.7%, excluding currency, predominantly due to the unfavorable impact of the
Saudi Arabia customs assessments, as noted above for net revenues.
Adjusted operating income increased by 29.5% on an organic basis, mainly reflecting: a favorable pricing
variance; favorable volume/mix, driven by the same factors as for net revenues noted above; and lower
manufacturing costs (primarily related to combustible products); partly offset by lower fees for certain distribution
rights, as noted above for net revenues; and higher marketing, administration and research costs.
Adjusted operating income margin increased by 5.6 points on an organic basis, as detailed in Schedule 8.
- 18 -

-- 18 of 48 --

Total Market, PMI Shipment & Market Share Commentaries
PMI Shipment Volume Third-Quarter Nine Months Year-to-Date
(million units) 2021 2020 Change 2021 2020 Change
Cigarettes 35,166 30,903 13.8 % 93,155 88,087 5.8 %
Heated Tobacco Units 577 179 +100% 1,485 834 78.1 %
Total Middle East & Africa 35,743 31,082 15.0 % 94,640 88,921 6.4 %
Third-Quarter
The estimated total market in the Middle East & Africa increased, mainly driven by:
• International Duty Free, up by 15.4%, reflecting the impact of reduced government travel restrictions and
increased passenger traffic in certain geographies; and
• Turkey, up by 12.5%, mainly reflecting the impact on adult smoker average daily consumption of the easing
of pandemic-related measures, coupled with increased in-bound tourism (particularly by Turkish expatriates);
partly offset by
• Tunisia, down by 30.1%, primarily reflecting an increased prevalence of illicit trade (mainly due to market
disruptions impacting product availability and the impact of price increases in July 2021).
PMI's total shipment volume increased by 15.0% to 35.7 billion units, notably driven by:
• PMI Duty Free, up by +100%, or by 43.8% excluding the net favorable impact of estimated distributor
inventory movements, reflecting a higher market share and the higher total market; and
• Turkey, up by 18.4%, primarily reflecting the higher total market and a higher market share, driven by adult
smoker up-trading (mainly benefiting Marlboro and Parliament);
partly offset by
• Egypt, down by 12.4%, primarily reflecting a lower market share mainly due to adult smoker down-trading to
products in the low-tax tier.
Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales
volume increased by 8.5%.
Nine Months Year-to-Date
The estimated total market in the Middle East & Africa increased, mainly driven by:
• Egypt, up by 14.3%, primarily reflecting a favorable comparison due to pandemic-related supply chain
shortages for competitors' products in 2020, as well as the favorable impact of adult smoker in-switching to
cigarettes (mainly in the low-tax tier) from other combustible tobacco products;
• South Africa, up by 26.9%, mainly reflecting a favorable comparison versus the second and third quarters of
2020, in which the total market was impacted by the pandemic-related ban on all tobacco sales from March
27th through August 17th, partly offset by a higher estimated prevalence of illicit trade stemming from the
ban; and
• Turkey, up by 6.6%, primarily reflecting the same factors as for the quarter, partly offset by a higher
estimated prevalence of illicit trade;
- 19 -

-- 19 of 48 --

partly offset by
• International Duty Free, down by 17.2%, primarily reflecting the impact of government travel restrictions and
reduced passenger traffic since the start of the pandemic in March 2020.
PMI's total shipment volume increased by 6.4% to 94.6 billion units, notably driven by:
• PMI Duty Free, up by 25.1%. Excluding the net favorable impact of estimated distributor inventory
movements (principally due to cigarettes), PMI in-market sales volume was down by 3.6%, primarily
reflecting the lower total market, partly offset by a higher market share driven by Marlboro; and
• Turkey, up by 14.6%, mainly reflecting the same factors as in the quarter;
partly offset by
• Egypt, down by 6.5%, mainly reflecting a lower market share (due primarily to the same factor as in the
quarter), partly offset by the higher total market.
SOUTH & SOUTHEAST ASIA REGION
Third-Quarter
Financial Summary -
Quarters Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other
(in millions)
Net Revenues $ 1,065 $ 1,071 (0.6) % (1.1) % (6) 6 — 14 (26) —
Operating Income $ 348 $ 402 (13.4) % (14.4) % (54) 4 — 14 (42) (30)
Asset Impairment & Exit
Costs (1) (4) — — % — % (4) — — — — (4)
Adjusted Operating
Income $ 352 $ 402 (12.4) % (13.4) % (50) 4 — 14 (42) (26)
Adjusted Operating
Income Margin 33.1 % 37.5 % (4.4)pp (4.6)pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues decreased by 1.1% on an organic basis, reflecting: unfavorable volume/mix, due to lower cigarette
volume (primarily in the Philippines, partly offset by Indonesia); partially offset by a favorable pricing variance,
driven by combustible pricing (mainly in the Philippines, partly offset by Indonesia).
Operating income decreased by 14.4%, excluding currency, primarily reflecting: unfavorable volume/mix, due to
the same factors as for net revenues noted above; and higher manufacturing costs; partly offset by a favorable
pricing variance.
Adjusted operating income decreased by 13.4% on an organic basis. Adjusted operating income margin
decreased by 4.6 points on the same basis, as detailed in Schedule 8.
- 20 -

-- 20 of 48 --

Nine Months Year-to-Date
Financial Summary -
Nine Months Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 3,284 $ 3,211 2.3 % (0.9) % 73 102 — (4) (25) —
Operating Income $ 1,208 $ 1,290 (6.4) % (9.1) % (82) 36 — (4) (81) (33)
Asset Impairment & Exit
Costs (1) (17) (11) (54.5) % (54.5) % (6) — — — — (6)
Adjusted Operating
Income $ 1,225 $ 1,301 (5.8) % (8.6) % (76) 36 — (4) (81) (27)
Adjusted Operating
Income Margin 37.3 % 40.5 % (3.2)pp (3.1)pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues decreased by 0.9% on an organic basis, reflecting: unfavorable volume/mix, mainly due to lower
cigarette volume (primarily the Philippines, partly offset by India and Indonesia), partially offset by favorable
cigarette mix (mainly in Indonesia and the Philippines). Pricing variance was slightly unfavorable, reflecting lower
pricing for combustible products (notably in Indonesia, largely offset by the Philippines).
Operating income decreased by 9.1%, excluding currency, primarily reflecting: unfavorable volume/mix, due to
the same factors as for net revenues noted above; and higher marketing, administration and research costs.
Adjusted operating income decreased by 8.6% on an organic basis. Adjusted operating income margin
decreased by 3.1 points on the same basis, as detailed in Schedule 8.
Total Market, PMI Shipment & Market Share Commentaries
PMI Shipment Volume Third-Quarter Nine Months Year-to-Date
(million units) 2021 2020 Change 2021 2020 Change
Cigarettes 35,578 37,238 (4.5) % 105,787 108,179 (2.2) %
Heated Tobacco Units 79 10 +100% 151 10 +100%
Total South & Southeast Asia 35,657 37,248 (4.3) % 105,938 108,189 (2.1) %
Third-Quarter
The estimated total market in South & Southeast Asia increased, mainly driven by:
• Bangladesh, up by 29.9%, primarily reflecting a favorable comparison versus the third quarter of 2020,
during which pandemic-related restrictions impacted tobacco product availability;
• India, up by 8.3%, mainly reflecting a favorable comparison versus the third quarter of 2020, during which
pandemic-related restrictions impacted the movement of certain products, including tobacco;
• Indonesia, up by 6.0%, primarily reflecting the growth of the tax-advantaged 'below tier one' segment and the
impact on adult smoker consumption of the easing of pandemic-related measures compared to the prior year
period; and
- 21 -

-- 21 of 48 --

• Pakistan, up by 29.3%, or by 14.1% excluding the net favorable impact of estimated trade inventory
movements, notably reflecting a lower prevalence of illicit trade (partly due to pandemic-related supply
disruptions for illicit products);
partly offset by
• the Philippines, down by 17.7%, or by 8.7% excluding the net unfavorable impact of estimated trade
inventory movements, primarily reflecting the impact of industry-wide price increases in the fourth quarter of
2020.
PMI's total shipment volume decreased by 4.3% to 35.7 billion units, mainly due to:
• the Philippines, down by 23.8%, primarily reflecting the lower total market and a lower market share (mainly
due to mid-price Fortune, reflecting the impact of price increases in the fourth quarter of 2020, partly offset
by Marlboro);
partly offset by
• Indonesia, up by 5.1%, primarily reflecting the higher total market.
Nine Months Year-to-Date
The estimated total market in South & Southeast Asia increased, mainly driven by:
• Bangladesh, up by 13.6%, primarily reflecting the same factor as in the quarter;
• India, up by 13.8%, mainly reflecting the same factor as in the quarter;
• Indonesia, up by 7.9%, primarily reflecting the same factors as in the quarter;
• Pakistan, up by 18.9%, notably reflecting the same factor as in the quarter; and
• Vietnam, up by 7.2%, mainly reflecting a lower prevalence of illicit trade due to pandemic-related supply
disruptions for illicit products;
partly offset by:
• the Philippines, down by 12.3%, primarily reflecting the same factor as in the quarter.
PMI's total shipment volume decreased by 2.1% to 105.9 billion units, notably due to:
• the Philippines, down by 20.3%, mainly reflecting the same factors as in the quarter;
partly offset by:
• Indonesia, up by 4.3%, primarily reflecting the higher total market, partly offset by a lower market share
(mainly due to adult smoker down-trading to the 'below tier one' segment as a result of significantly lower
retail prices, partly offset by share growth for PMI's premium and hand-rolled portfolio); and
• Pakistan, up by 14.2%, mainly reflecting the higher total market, partly offset by a lower market share.
- 22 -

-- 22 of 48 --

EAST ASIA & AUSTRALIA REGION
Third-Quarter
Financial Summary -
Quarters Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 1,523 $ 1,358 12.2 % 12.7 % 165 (7) — 47 125 —
Operating Income $ 631 $ 637 (0.9) % 2.7 % (6) (23) — 47 3 (33)
Asset Impairment & Exit
Costs (1) (21) — — % — % (21) — — — — (21)
Adjusted Operating
Income $ 652 $ 637 2.4 % 6.0 % 15 (23) — 47 3 (12)
Adjusted Operating
Income Margin 42.8 % 46.9 % (4.1)pp (2.8)pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues increased by 12.7% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher
heated tobacco unit volume and favorable device volume/mix (predominantly in Japan, driven by the launch of
IQOS ILUMA), partly offset by unfavorable cigarette mix (primarily in Japan) and lower cigarette volume
(particularly in Australia, partly offset by Japan); and a favorable pricing variance, primarily driven by higher
heated tobacco, combustible and device pricing in Japan.
Operating income increased by 2.7%, excluding currency, mainly reflecting: a favorable pricing variance; and
lower manufacturing costs (primarily related to reduced-risk products in Japan); partly offset by higher marketing,
administration and research costs (notably due to the launch of IQOS ILUMA in Japan and higher asset
impairment and exit costs, mainly related to product distribution restructuring in South Korea). Volume/mix was
slightly favorable, notably reflecting higher heated tobacco unit and cigarette volume in Japan, largely offset by
lower cigarette volume in Australia and unfavorable cigarette mix in Japan.
Adjusted operating income increased by 6.0% on an organic basis. Adjusted operating income margin
decreased by 2.8 points on the same basis, as detailed in Schedule 8.
- 23 -

-- 23 of 48 --

Nine Months Year-to-Date
Financial Summary -
Nine Months Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 4,509 $ 4,045 11.5 % 9.0 % 464 101 — 240 123 —
Operating Income $ 2,041 $ 1,792 13.9 % 14.2 % 249 (6) — 240 21 (6)
Asset Impairment & Exit
Costs (1) (67) (13) -(100)% -(100)% (54) — — — — (54)
Adjusted Operating
Income $ 2,108 $ 1,805 16.8 % 17.1 % 303 (6) — 240 21 48
Adjusted Operating
Income Margin 46.8 % 44.6 % 2.2pp 3.4pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues increased by 9.0% on an organic basis, mainly reflecting: a favorable pricing variance, primarily
driven by higher heated tobacco and combustible pricing in Japan, partly offset by lower combustible pricing in
Australia; and favorable volume/mix, mainly driven by higher heated tobacco unit volume and favorable device
volume/mix in Japan (driven by the launch of IQOS ILUMA), partly offset by lower cigarette volume (primarily in
Australia, Japan and South Korea) and unfavorable cigarette mix (mainly in Australia and Japan).
Operating income increased by 14.2%, excluding currency, mainly reflecting: a favorable pricing variance; lower
manufacturing costs (primarily related to reduced-risk products in Japan); and favorable volume/mix, driven by
higher heated tobacco unit volume in Japan, partly offset by lower cigarette volume (primarily in Australia, Japan
and South Korea), unfavorable cigarette mix (mainly in Australia and Japan) and unfavorable heated tobacco
unit mix in Japan; partially offset by higher marketing, administration and research costs (notably reflecting the
same factors as in the quarter).
Adjusted operating income increased by 17.1%, on an organic basis. Adjusted operating income margin
increased by 3.4 points on the same basis, as detailed in Schedule 8.
Total Market, PMI Shipment & Market Share Commentaries
PMI Shipment Volume Third-Quarter Nine Months Year-to-Date
(million units) 2021 2020 Change 2021 2020 Change
Cigarettes 11,120 10,784 3.1 % 33,450 35,154 (4.8) %
Heated Tobacco Units 9,435 8,601 9.7 % 28,478 24,799 14.8 %
Total East Asia & Australia 20,555 19,385 6.0 % 61,928 59,953 3.3 %
Third-Quarter
The estimated total market in East Asia & Australia, excluding China, decreased, primarily due to:
• Australia, down by 28.0%, or by 18.3% excluding the net unfavorable impact of estimated trade inventory
movements, mainly reflecting the impact of the ending of the pandemic-related wage subsidy by the
government, coupled with the impact of pandemic-related restrictions in the quarter;
• Japan, down by 2.8%, primarily reflecting the impact of the October 2020 excise tax-driven price increases;
- 24 -

-- 24 of 48 --

• South Korea, down by 5.2%, or by 0.9% excluding the net unfavorable impact of estimated trade inventory
movements, mainly reflecting the structural market trend; and
• Taiwan, down by 10.8%, primarily reflecting impact of pandemic-related restrictions in the quarter.
PMI's total shipment volume increased by 6.0% to 20.6 billion units, mainly driven by:
• Japan, up by 14.6%, or by 1.0% excluding the net favorable impact of estimated distributor inventory
movements, primarily reflecting a higher market share (driven by heated tobacco units), partly offset by the
lower total market;
partly offset by
• South Korea, down by 5.9%, mainly reflecting the lower total market and a lower market share (due to
cigarettes).
Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales
volume declined by 1.7%.
Nine Months Year-to-Date
The estimated total market in East Asia & Australia, excluding China, decreased, mainly due to:
• Australia, down by 14.5%, primarily reflecting the same factors as in the quarter;
• Japan, down by 3.7%, mainly reflecting the same factor as in the quarter; and
• South Korea, down by 1.4%, primarily reflecting the same factor as in the quarter, partly offset by the impact
of pandemic-related subsidies on adult smoker average daily consumption.
PMI's total shipment volume increased by 3.3% to 61.9 billion units, mainly driven by:
• Japan, up by 7.2%, or by 1.3% excluding the net favorable impact of estimated distributor inventory
movements, primarily reflecting the same factors as in the quarter;
partly offset by
• South Korea, down by 5.3%, mainly reflecting the same factors as in the quarter.
Excluding the net favorable impact of estimated distributor inventory movements, PMI's total in-market sales
volume declined by 0.6%.
- 25 -

-- 25 of 48 --

AMERICAS REGION
Third-Quarter
Financial Summary -
Quarters Ended
September 30,
Change
Fav./(Unfav.) Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 456 $ 400 14.0 % 9.0 % 56 20 — 16 21 (1)
Operating Income $ 121 $ 110 10.0 % 6.4 % 11 4 — 16 3 (12)
Asset Impairment & Exit
Costs (1) (1) — — % — % (1) — — — — (1)
Adjusted Operating
Income $ 122 $ 110 10.9 % 7.3 % 12 4 — 16 3 (11)
Adjusted Operating
Income Margin 26.8 % 27.5 % (0.7)pp (0.4)pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues increased by 9.0% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher
cigarette volume (primarily in Colombia and Mexico) and higher device volume (notably in Canada); and a
favorable pricing variance driven by combustible products (notably in Argentina and Mexico).
Operating income increased by 6.4%, excluding currency, primarily reflecting: a favorable pricing variance; partly
offset by higher manufacturing costs; and higher marketing, administration and research costs.
Adjusted operating income increased by 7.3% on an organic basis. Adjusted operating income margin
decreased by 0.4 points on the same basis, as detailed in Schedule 8.
Nine Months Year-to-Date
Financial Summary -
Nine Months Ended
September 30,
Change
Fav./(Unfav.)
Variance
Fav./(Unfav.)
2021 2020 Total Excl.
Curr. Total Cur-
rency Acqui-
sitions Price Vol/
Mix Cost/
Other	(in millions)
Net Revenues $ 1,320 $ 1,216 8.6 % 5.4 % 104 38 — 28 37 1
Operating Income $ 367 $ 328 11.9 % 8.2 % 39 12 — 28 (3) 2
Asset Impairment & Exit
Costs (1) (6) (4) (50.0) % (50.0) % (2) — — — — (2)
Adjusted Operating
Income $ 373 $ 332 12.3 % 8.7 % 41 12 — 28 (3) 4
Adjusted Operating
Income Margin 28.3 % 27.3 % 1.0pp 0.9pp
(1) Included in marketing, administration and research costs at the consolidated operating income level.
Net revenues increased by 5.4% on an organic basis, mainly reflecting: favorable volume/mix, primarily driven by
higher cigarette volume (mainly in Brazil and Mexico) and higher device volume (notably in Canada); and a
favorable pricing variance, driven by higher combustible pricing (notably in Argentina and Colombia).
- 26 -

-- 26 of 48 --

Operating income increased by 8.2%, excluding currency, primarily reflecting: a favorable pricing variance; and
lower marketing, administration and research costs; partly offset by higher manufacturing costs.
Adjusted operating income increased by 8.7% on an organic basis. Adjusted operating income margin increased
by 0.9 points on the same basis, as detailed in Schedule 8.
Total Market, PMI Shipment & Market Share Commentaries
PMI Shipment Volume Third-Quarter Nine Months Year-to-Date
(million units) 2021 2020 Change 2021 2020 Change
Cigarettes 15,994 15,699 1.9 % 46,092 45,542 1.2 %
Heated Tobacco Units 221 114 93.9 % 466 316 47.5 %
Total Americas 16,215 15,813 2.5 % 46,558 45,858 1.5 %
Third-Quarter
The estimated total market in Americas decreased, notably due to:
• Argentina, down by 2.1%, primarily reflecting the impact of price increases;
• Canada, down by 12.7%, notably reflecting the impact of price increases and out-switching from cigarettes to
e-vapor products;
partly offset by
• Colombia, up by 13.4%, primarily reflecting the impact on adult smoker average daily consumption of the
easing of pandemic-related measures.
PMI's total shipment volume increased by 2.5% to 16.2 billion units, notably driven by:
• Colombia, up by 11.0%, primarily reflecting the higher total market; and
• Mexico, up by 3.9%, mainly reflecting a higher market share driven by Marlboro;
partly offset by
• Argentina, down by 2.5%, primarily reflecting the lower total market.
Nine Months Year-to-Date
The estimated total market in Americas increased, mainly driven by:
• Argentina, up by 7.5%, primarily reflecting a lower estimated prevalence of illicit trade and a favorable
comparison related to retail out-of-stock in the second quarter of 2020 (due to temporary factory shutdowns
related to the pandemic), partly offset by the impact of price increases;
• Brazil, up by 5.4%, mainly reflecting a lower estimated prevalence of illicit trade due to: reduced price gaps
with legal products and the impact of border restrictions imposed as a result of the pandemic; and
• Mexico, up by 3.0%, primarily reflecting the impact on adult smoker average daily consumption of the easing
of pandemic-related measures coupled with the impact of increased in-bound tourism;
partly offset by
• Canada, down by 8.5%, mainly reflecting the same factors as in the quarter.
- 27 -

-- 27 of 48 --

PMI's total shipment volume increased by 1.5% to 46.6 billion units, primarily driven by:
• Brazil, up by 6.4%, mainly reflecting the higher total market and a higher market share driven by
Chesterfield; and
• Mexico, up by 3.9%, primarily reflecting the higher total market and a higher market share driven by
Marlboro;
partly offset by
• Argentina, down by 2.4%, mainly reflecting a lower market share (primarily due to adult smoker down-trading
to ultra-low-price brands produced by local manufacturers).
OTHER
Third-Quarter and Nine Months Year-to-Date
Following the acquisitions of Fertin Pharma A/S, OtiTopic, Inc. and Vectura Group plc., PMI added the "Other"
category in the third quarter of 2021. Business operations for the Other category are evaluated separately from
the geographical operating segments.
Due to the timing of the Fertin Pharma and Vectura acquisitions, the company did not record the immaterial
results of operations from these two acquisitions in its consolidated statements of earnings from the acquisition
dates through September 30, 2021.
PMI accounted for the OtiTopic transaction as an asset acquisition since the in-process research and
development of the dry powder inhalation aspirin treatment represented substantially all of the fair value of the
gross assets acquired and had no alternative future use. As a result, PMI recorded a pre-tax charge of $51
million to research and development costs within marketing, administration and research costs of the Other
category for the third quarter and the nine months year-to-date. The charge has been excluded from adjusted
results.
- 28 -

-- 28 of 48 --

Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future
and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue
to smoke, society, the company, its shareholders and other stakeholders. PMI is a leading international tobacco
company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated
electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In
addition, versions of PMI's IQOS Platform 1 device and consumables have received marketing authorizations
from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA)
pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified
Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to
promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-
free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product
development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free
products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free product
portfolio includes heat-not-burn products, nicotine-containing vapor products and oral nicotine products. As of
September 30, 2021, PMI's smoke-free products are available for sale in 70 markets in key cities or nationwide,
and PMI estimates that approximately 14.9 million adults around the world have already switched to IQOS and
stopped smoking. For more information, please visit www.pmi.com and www.pmiscience.com.
Forward-Looking and Cautionary Statements
This press release contains projections of future results and other forward-looking statements. Achievement of
future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties
materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those
contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could
cause actual results and outcomes to differ materially from those contained in any forward-looking statements
made by PMI.
PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and
regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult
consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of
tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related
to tobacco use and intellectual property; intense competition; the effects of global and individual country
economic, regulatory and political developments, natural disasters and conflicts; changes in adult smoker
behavior; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental
investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to
repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and
quality of tobacco and other agricultural products and raw materials, as well as components and materials for our
electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies.
PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to produce and
commercialize reduced-risk products or if regulation or taxation do not differentiate between such products and
cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or
improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio
internally or through acquisitions and the development of strategic business relationships; or if it is unable to
- 29 -

-- 29 of 48 --

attract and retain the best global talent. Future results are also subject to the lower predictability of our reduced-
risk product category's performance.
In addition, PMI’s business risks also include risks and uncertainties related to PMI’s acquisitions of Fertin
Pharma A/S (“Fertin”), OtiTopic, Inc. ("OtiTopic") and Vectura Group plc (“Vectura”), including, amongst other
things: (1) the possibility that the integration of the operations of Fertin and Vectura with those of PMI may be
more difficult and/or take longer than anticipated, and may not accelerate PMI’s desired entry into additional
smoke-free and beyond nicotine platforms as quickly as anticipated; (2) the possibility that the respective
integrations of Fertin and Vectura into PMI may be more costly than anticipated and may have unanticipated
adverse results relating to Fertin, Vectura or PMI’s existing businesses; (3) the inability to gain access to or
acquire differentiated proprietary assets, technology and/or pharmaceutical development expertise as
anticipated by these acquisitions; (4) risks associated with third-party contracts containing consent and/or other
contractual provisions that may be triggered by the acquisitions; (5) the success of the research and
development efforts of Fertin, OtiTopic and Vectura, including the ability to obtain regulatory approval for new
products, and the ability to commercialize or license these new products; (6) any unanticipated safety, quality or
efficacy concerns and the impact of identified concerns associated with the products developed by Fertin,
OtiTopic and Vectura; and (7) the ability of PMI to retain key personnel of Fertin and Vectura, or hire key talent to
work in the Fertin and Vectura businesses due to their affiliation with PMI.
The COVID-19 pandemic has created significant societal and economic disruption, and resulted in closures of
stores, factories and offices, and restrictions on manufacturing, distribution and travel, all of which will adversely
impact our business, results of operations, cash flows and financial position during the continuation of the
pandemic. Our business continuity plans and other safeguards may not be effective to mitigate the impact of the
pandemic. Currently, significant risks include our diminished ability to convert adult smokers to our reduced-risk
products, significant volume declines in our duty-free business and certain other key markets, disruptions or
delays in our manufacturing and supply chain, increased currency volatility, and delays in certain cost saving,
transformation and restructuring initiatives. Our business could also be adversely impacted if key personnel or a
significant number of employees or business partners become unavailable due to the continuation of the
COVID-19 pandemic. The significant adverse impact of COVID-19 on the economic or political conditions in
markets in which we operate could result in changes to the preferences of our adult consumers and lower
demand for our products, particularly for our mid-price or premium-price brands. Continuation of the pandemic
could disrupt our access to the credit markets or increase our borrowing costs. Governments may temporarily be
unable to focus on the development of science-based regulatory frameworks for the development and
commercialization of reduced-risk products or on the enforcement or implementation of regulations that are
significant to our business. In addition, messaging about the potential negative impacts of the use of our
products on COVID-19 risks may lead to increasingly restrictive regulatory measures on the sale and use of our
products, negatively impact demand for our products, the willingness of adult consumers to switch to our
reduced-risk products and our efforts to advocate for the development of science-based regulatory frameworks
for the development and commercialization of reduced-risk products.
The impact of these risks also depends on factors beyond our knowledge or control, including the duration and
severity of the pandemic, its recurrence in our key markets, actions taken to contain its spread and to mitigate its
public health effects, and the ultimate economic consequences thereof.
- 30 -

-- 30 of 48 --

PMI is further subject to other risks detailed from time to time in its publicly filed documents, including the Form
10-Q for the quarter ended June 30, 2021. PMI cautions that the foregoing list of important factors is not a
complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-
looking statement that it may make from time to time, except in the normal course of its public disclosure
obligations.
Key Terms, Definitions and Explanatory Notes
General
• "PMI" refers to Philip Morris International Inc. and its subsidiaries. Trademarks and service marks that are
the registered property of, or licensed by, the subsidiaries of PMI, are italicized.
• Comparisons are made to the same prior-year period unless otherwise stated.
• References to total industry, total market, PMI shipment volume and PMI market share performance reflect
cigarettes and heated tobacco units, unless otherwise stated.
• References to total international market, defined as worldwide cigarette and heated tobacco unit volume
excluding the U.S., total industry, total market and market shares are PMI estimates for tax-paid products
based on the latest available data from a number of internal and external sources and may, in defined
instances, exclude the People's Republic of China and/or PMI's duty free business.
• 2020 and 2021 estimates for total industry volume and market share in certain geographies reflect limitations
on the availability and accuracy of industry data during pandemic-related restrictions.
• "Combustible products" is the term PMI uses to refer to cigarettes and OTP, combined.
• In-market sales, or "IMS," is defined as sales to the retail channel, depending on the market and distribution
model.
• "Total shipment volume" is defined as the combined total of cigarette shipment volume and heated tobacco
unit shipment volume.
• "Americas" refers to the former Latin America & Canada segment, which was renamed as the Americas
segment as of the third quarter of 2021.
• "North Africa" is defined as Algeria, Egypt, Libya, Morocco and Tunisia.
• "The GCC" (Gulf Cooperation Council) is defined as Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the
United Arab Emirates (UAE).
• "Southeast Europe" is defined as Albania, Bosnia & Herzegovina, Kosovo, Montenegro, North Macedonia
and Serbia.
• Following the acquisitions of Fertin Pharma A/S, OtiTopic, Inc. and Vectura Group plc., PMI added the
"Other" category in the third quarter of 2021. Business operations for the Other category are evaluated
separately from the geographical operating segments.
• Following the deconsolidation of PMI's Canadian subsidiary, Rothmans, Benson & Hedges, Inc. (RBH) on
March 22, 2019, PMI continues to report the volume of brands sold by RBH for which other PMI subsidiaries
are the trademark owner. These include HEETS, Next, Philip Morris and Rooftop.
• From time to time, PMI’s shipment volumes are subject to the impact of distributor inventory movements,
and estimated total industry/market volumes are subject to the impact of inventory movements in various
trade channels that include estimated trade inventory movements of PMI’s competitors arising from market-
specific factors that significantly distort reported volume disclosures. Such factors may include changes to
the manufacturing supply chain, shipment methods, consumer demand, timing of excise tax increases or
other influences that may affect the timing of sales to customers. In such instances, in addition to reviewing
PMI shipment volumes and certain estimated total industry/market volumes on a reported basis,
management reviews these measures on an adjusted basis that excludes the impact of distributor and/or
estimated trade inventory movements. Management also believes that disclosing PMI shipment volumes and
estimated total industry/market volumes in such circumstances on a basis that excludes the impact of
distributor and/or estimated trade inventory movements, such as on an IMS basis, improves the
comparability of performance and trends for these measures over different reporting periods.
- 31 -

-- 31 of 48 --

Financial
• Net revenues related to combustible products refer to the operating revenues generated from the sale of
these products, including shipping and handling charges billed to customers, net of sales and promotion
incentives, and excise taxes. PMI recognizes revenue when control is transferred to the customer, typically
either upon shipment or delivery of goods.
• Net revenues related to RRPs represent the sale of heated tobacco units, heat-not-burn devices and related
accessories, and other nicotine-containing products, primarily e-vapor and oral nicotine products, including
shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes.
PMI recognizes revenue when control is transferred to the customer, typically either upon shipment or
delivery of goods.
• Adjusted net revenues exclude the impact related to the Saudi Arabia customs assessments.
• "Cost of sales" consists principally of: tobacco leaf, non-tobacco raw materials, labor and manufacturing
costs; shipping and handling costs; and the cost of devices produced by third-party electronics
manufacturing service providers. Estimated costs associated with device warranty programs are generally
provided for in cost of sales in the period the related revenues are recognized.
• "Marketing, administration and research costs" include the costs of marketing and selling our products, other
costs generally not related to the manufacture of our products (including general corporate expenses), and
costs incurred to develop new products. The most significant components of our marketing, administration
and research costs are marketing and sales expenses and general and administrative expenses.
• "Cost/Other" in the Consolidated Financial Summary table of total PMI and the six geographical segments of
this release reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost
component); marketing, administration and research costs (including asset impairment and exit costs); and
amortization of intangibles. “Cost/Other” also includes the currency-neutral net revenue variance, unrelated
to volume/mix and price components, attributable to: fees for certain distribution rights billed to customers in
certain markets in the ME&A Region and the Saudi Arabia customs assessment net revenue adjustment.
• "Adjusted Operating Income Margin" is calculated as adjusted operating income, divided by adjusted net
revenues.
• "Adjusted EBITDA" is defined as earnings before interest, taxes, depreciation, amortization and equity
(income)/loss in unconsolidated subsidiaries, excluding asset impairment and exit costs, and unusual items.
• "Net debt" is defined as total debt, less cash and cash equivalents.
• Growth rates presented on an organic basis reflect currency-neutral underlying results.
• Management reviews net revenues, operating income, operating income margin, operating cash flow and
earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and other
items such as acquisitions, asset impairment and exit costs, tax items and other special items. Organic
growth rates reflect the way management views underlying performance for these measures. PMI believes
that such measures provide useful insight into underlying business trends and results.
• Management reviews these measures because they exclude changes in currency exchange rates and other
factors that may distort underlying business trends, thereby improving the comparability of PMI’s business
performance between reporting periods. Furthermore, PMI uses several of these measures in its
management compensation program to promote internal fairness and a disciplined assessment of
performance against company targets. PMI discloses these measures to enable investors to view the
business through the eyes of management.
• Non-GAAP measures used in this release should neither be considered in isolation nor as a substitute for
the financial measures prepared in accordance with U.S. GAAP. For a reconciliation of non-GAAP measures
to the most directly comparable U.S. GAAP measures, see the relevant schedules provided with this press
release.
• U.S. GAAP Treatment of Argentina as a Highly Inflationary Economy. Following the categorization of
Argentina by the International Practices Task Force of the Center for Audit Quality as a country with a three-
year cumulative inflation rate greater than 100%, the country is considered highly inflationary in accordance
with U.S. GAAP. Consequently, PMI began to account for the operations of its Argentinian affiliates as highly
inflationary, and to treat the U.S. dollar as the functional currency of the affiliates, effective July 1, 2018.
• "Fair value adjustment for equity security investments" reflects the adjustment resulting from share price
movements in passive investments for publicly traded entities that are not controlled or influenced by PMI.
- 32 -

-- 32 of 48 --

Under U.S. GAAP, such adjustments are required, since January 1, 2018, to be reflected directly in the
income statement.
Reduced-Risk Products
• Reduced-risk products (“RRPs”) is the term PMI uses to refer to products that present, are likely to present,
or have the potential to present less risk of harm to smokers who switch to these products versus continuing
smoking. PMI has a range of RRPs in various stages of development, scientific assessment and
commercialization. PMI's RRPs are smoke-free products that contain and/or generate far lower quantities of
harmful and potentially harmful constituents than found in cigarette smoke.
• "Heated tobacco units," or "HTUs," is the term PMI uses to refer to heated tobacco consumables, which
include the company's HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro and HEETS
FROM MARLBORO (defined collectively as HEETS), Marlboro Dimensions, Marlboro HeatSticks,
Parliament HeatSticks and TEREA, as well as the KT&G-licensed brands, Fiit and Miix (outside of Korea).
• Market share for HTUs is defined as the total sales volume for HTUs as a percentage of the total estimated
sales volume for cigarettes and HTUs.
• Unless otherwise stated, all references to IQOS are to PMI's Platform 1 IQOS devices and heated tobacco
consumables.
• The IQOS heat-not-burn device is a precisely controlled heating device into which a specially designed and
proprietary tobacco unit is inserted and heated to generate an aerosol.
• "PMI heat-not-burn products" include licensed KT&G heat-not-burn products.
• "PMI HTUs" include licensed KT&G HTUs.
• “Total IQOS users” is defined as the estimated number of Legal Age (minimum 18 years) users of PMI heat-
not-burn products for which PMI HTUs represented at least 5% of their daily tobacco consumption over the
past seven days. Note: as of December 2020, PMI heat-not-burn products and HTUs include licensed KT&G
heat-not-burn products and HTUs, respectively.
• The estimated number of adults who have "switched to IQOS and stopped smoking" reflects:
◦ for markets where there are no heat-not-burn products other than PMI heat-not-burn products: daily
individual consumption of PMI HTUs represents the totality of their daily tobacco consumption in the
past seven days;
◦ for markets where PMI heat-not-burn products are among other heat-not-burn products: daily
individual consumption of HTUs represents the totality of their daily tobacco consumption in the past
seven days, of which at least 70% is PMI HTUs.
Note: as of December 2020, PMI heat-not-burn products and HTUs include licensed KT&G heat-not-burn
products and HTUs, respectively.
IQOS in the United States
• On April 30, 2019, the U.S. Food and Drug Administration (FDA) announced that the marketing of a version
of PMI's Platform 1 product, namely, IQOS 2.4, together with its heated tobacco units (the term PMI uses to
refer to heated tobacco consumables), is appropriate for the protection of public health and authorized it for
sale in the U.S. The FDA’s decision followed its comprehensive assessment of PMI’s premarket tobacco
product applications (PMTAs) submitted to the Agency in 2017.
• In the third quarter of 2019, PMI brought IQOS 2.4 and three variants of its heated tobacco units to the U.S.
through its license with Altria Group, Inc., whose subsidiary, Philip Morris USA Inc., is responsible for
marketing the product and complying with the provisions set forth in the FDA's marketing orders.
• On July 7, 2020, the FDA authorized the marketing of a version of PMI's Platform 1 product, namely, IQOS
2.4, together with its heated tobacco units, as a Modified Risk Tobacco Product (MRTP). In doing so, the
agency found that an IQOS exposure modification order is appropriate to promote the public health. The
decision followed a review of the extensive scientific evidence package PMI submitted to the FDA in
December 2016 to support its MRTP applications.
• On December 7, 2020, the FDA confirmed that the marketing of a version of PMI's Platform 1 product,
namely, IQOS 3, is appropriate for the protection of public health and authorized it for sale in the U.S. The
FDA’s decision followed an assessment of a PMI's PMTA filed with the agency in March 2020.
• Shipment volume of heated tobacco units to the U.S. is included in the heated tobacco unit shipment volume
- 33 -

-- 33 of 48 --

of the Americas segment. Revenues from shipments of Platform 1 devices, heated tobacco units and
accessories to Altria Group, Inc. for sale under license in the U.S. are included in Net Revenues of the
Americas.
• In April 2020, affiliates of British American Tobacco plc (BAT) filed a complaint against PMI, Philip Morris
Products S.A., Altria Group, Inc., and its subsidiaries before the International Trade Commission (ITC). On
May 14, 2021, the administrative law judge issued an Initial and Recommended Determination (ID/RD)
finding that the IQOS Platform 1 product commercialized in the U.S. infringes two of the three patents
asserted by Plaintiffs, recommending that the ITC issue a Limited Exclusion Order (LEO) against infringing
products and recommending against a cease-and-desist order (CDO), as well as recommending against a
bond pending Presidential review of the ITC's Final Determination (FD). On September 29, 2021, the ITC
issued its FD, in which it upheld the finding of infringement in the ID and found a subsequent violation. The
ITC issued a LEO prohibiting the importation of infringing tobacco heating articles and components thereof
and CDOs against Philip Morris USA, Inc. and Altria Client Services, LLC. The case is now in a 60-day
Presidential Review Period. PMI will appeal the patent and statutory issues at the appropriate time and has
contingency plans underway, including domestic production. Furthermore, BAT lawsuits based on the same
patent families have repeatedly and universally failed in European courts and the European Patent Office.
The decision has no bearing outside the United States.
- 34 -

-- 34 of 48 --

Appendix 1
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Key Market Data
Quarters Ended September 30,
Market
Total Market,
bio units
PMI Shipments, bio units PMI Market Share, % (1)
Total Cigarette HTU Total HTU
2021 2020 %
Change 2021 2020 %
Change 2021 2020 %
Change 2021 2020 %
Change 2021 2020 pp
Change 2021 2020 pp
Change
Total 679.6 674.3 0.8 188.3 184.4 2.1 164.8 165.5 (0.4) 23.5 19.0 23.8 28.0 28.0 — 3.6 3.0 0.6
European Union
France 9.0 9.8 (8.0) 3.7 4.2 (10.8) 3.6 4.1 (11.7) 0.1 — — 44.0 45.3 (1.3) 0.6 0.5 0.1
Germany 20.5 20.4 0.7 7.3 7.4 (1.1) 6.8 7.0 (3.8) 0.6 0.4 50.0 35.8 36.4 (0.6) 2.8 1.9 0.9
Italy 19.2 18.8 2.1 9.4 9.7 (3.1) 7.3 8.2 (11.1) 2.1 1.5 41.0 52.9 52.1 0.8 10.8 7.8 3.0
Poland 14.0 13.5 3.4 5.3 5.1 3.8 4.5 4.5 (0.3) 0.8 0.6 32.7 38.0 37.8 0.2 6.0 4.7 1.3
Spain 12.1 11.7 3.1 3.4 3.7 (9.1) 3.2 3.6 (10.1) 0.1 0.1 25.3 32.1 32.2 (0.1) 1.1 0.9 0.2
Eastern Europe
Russia 59.3 59.8 (0.9) 18.8 18.6 0.7 15.0 15.5 (3.8) 3.8 3.1 23.3 32.0 31.8 0.2 6.9 5.8 1.1
Middle East & Africa
Saudi Arabia 5.4 5.5 (1.6) 2.3 2.4 (4.2) 2.3 2.4 (5.0) — — — 40.8 36.9 3.9 1.1 0.4 0.7
Turkey 36.1 32.1 12.5 16.0 13.5 18.4 16.0 13.5 18.4 — — — 44.2 42.0 2.2 — — —
South & Southeast Asia
Indonesia 74.3 70.1 6.0 20.8 19.8 5.1 20.8 19.8 5.1 — — — 28.0 28.2 (0.2) — — —
Philippines 14.4 17.5 (17.7) 8.9 11.7 (23.8) 8.9 11.7 (24.1) — — — 61.9 66.8 (4.9) 0.3 — 0.3
East Asia & Australia
Australia 2.3 3.2 (28.0) 0.8 1.0 (19.0) 0.8 1.0 (19.0) — — — 33.7 29.8 3.9 — — —
Japan 39.7 40.8 (2.8) 13.6 11.9 14.6 5.4 4.6 18.4 8.2 7.3 12.2 38.3 36.9 1.4 22.9 20.4 2.5
South Korea 19.2 20.2 (5.2) 3.7 3.9 (5.9) 2.5 2.7 (7.1) 1.2 1.2 (3.2) 19.2 19.5 (0.3) 6.1 6.0 0.1
Americas
Argentina 8.4 8.6 (2.1) 4.8 4.9 (2.5) 4.8 4.9 (2.5) — — — 56.6 56.8 (0.2) — — —
Mexico 7.8 7.7 0.8 5.0 4.8 3.9 5.0 4.8 3.8 — — — 64.6 62.7 1.9 0.3 0.2 0.1
(1) Market share estimates are calculated using IMS data
Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

-- 35 of 48 --

Appendix 2
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Key Market Data
Nine Months Ended September 30,
Market
Total Market,
bio units
PMI Shipments, bio units PMI Market Share, % (1)
Total Cigarette HTU Total HTU
2021 2020 %
Change 2021 2020 %
Change 2021 2020 %
Change 2021 2020 %
Change 2021 2020 pp
Change 2021 2020 pp
Change
Total 1,946.1 1,897.3 2.6 536.1 528.2 1.5 466.5 473.8 (1.6) 69.6 54.4 27.9 27.3 27.9 (0.6) 3.5 2.9 0.6
European Union
France 26.3 28.0 (6.1) 11.6 12.7 (8.3) 11.4 12.5 (8.8) 0.2 0.1 36.9 43.7 44.9 (1.2) 0.6 0.5 0.1
Germany 56.5 56.4 0.1 21.6 22.0 (1.4) 20.0 20.8 (4.0) 1.7 1.2 44.2 38.3 38.9 (0.6) 3.0 2.1 0.9
Italy 53.0 50.8 4.2 28.9 26.7 8.1 22.4 22.8 (1.5) 6.5 4.0 62.8 52.9 52.0 0.9 11.1 7.6 3.5
Poland 37.2 35.0 6.4 13.9 13.6 2.3 11.7 12.1 (2.7) 2.2 1.6 40.9 37.4 38.9 (1.5) 5.9 4.5 1.4
Spain 32.2 31.7 1.4 10.2 10.1 1.1 9.8 9.8 0.5 0.4 0.3 18.0 31.5 31.5 — 1.2 1.0 0.2
Eastern Europe
Russia 163.7 163.4 0.2 52.0 51.6 0.9 40.4 42.3 (4.5) 11.7 9.3 25.3 31.5 32.3 (0.8) 7.2 6.1 1.1
Middle East & Africa
Saudi Arabia 16.2 15.8 2.0 6.6 6.2 5.3 6.4 6.2 3.5 0.2 — — 41.5 38.5 3.0 0.9 0.2 0.7
Turkey 92.1 86.4 6.6 40.4 35.3 14.6 40.4 35.3 14.6 — — — 43.9 40.8 3.1 — — —
South & Southeast Asia
Indonesia 217.4 201.4 7.9 60.8 58.3 4.3 60.8 58.3 4.3 — — — 28.0 28.9 (0.9) — — —
Philippines 41.2 47.0 (12.3) 25.6 32.1 (20.3) 25.5 32.1 (20.6) 0.1 — — 62.2 68.4 (6.2) 0.3 — 0.3
East Asia & Australia
Australia 7.1 8.3 (14.5) 2.3 2.5 (6.4) 2.3 2.5 (6.4) — — — 32.4 29.6 2.8 — — —
Japan 107.3 111.4 (3.7) 41.6 38.8 7.2 16.8 17.7 (4.9) 24.7 21.1 17.3 38.6 36.7 1.9 23.0 20.0 3.0
South Korea 54.1 54.8 (1.4) 10.7 11.3 (5.3) 7.2 7.8 (7.6) 3.5 3.5 (0.3) 19.7 20.7 (1.0) 6.4 6.4 —
Americas
Argentina 26.1 24.3 7.5 14.6 14.9 (2.4) 14.6 14.9 (2.4) — — — 55.8 61.5 (5.7) — — —
Mexico 22.6 21.9 3.0 14.1 13.6 3.9 14.1 13.6 3.7 0.1 — — 62.5 62.0 0.5 0.3 0.2 0.1
(1) Market share estimates are calculated using IMS data
Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%

-- 36 of 48 --

Schedule 1
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Diluted Earnings Per Share (EPS)
($ in millions, except per share data) / (Unaudited)
Quarters Ended Diluted EPS Nine Months Ended
September 30, September 30,
$ 1.55 2021 Diluted Earnings Per Share (1) $ 4.48
$ 1.48 2020 Diluted Earnings Per Share (1) $ 3.90
$ 0.07 Change $ 0.58
4.7 % % Change 14.9 %
Reconciliation:
$ 1.48 2020 Diluted Earnings Per Share (1) $ 3.90
— 2020 Asset impairment and exit costs 0.04
— 2020 Fair value adjustment for equity security investments 0.04
(0.06) 2020 Tax items (0.06)
(0.02) 2021 Asset impairment and exit costs (0.09)
— 2021 Saudi Arabia customs assessments (0.14)
(0.03) 2021 Asset acquisition cost (0.03)
0.02 2021 Equity investee ownership dilution 0.02
— 2021 Tax items —
0.04 Currency 0.18
0.01 Interest (0.01)
0.04 Change in tax rate 0.07
0.07 Operations (2) 0.56
$ 1.55 2021 Diluted Earnings Per Share (1) $ 4.48
(1) Basic and diluted EPS were calculated using the following (in millions):
Quarters Ended Nine Months Ended
September 30, September 30,
2021 2020 2021 2020
$ 2,426 $ 2,307 Net Earnings attributable to PMI $ 7,016 $ 6,080
7 5
Less: Distributed and undistributed earnings
attributable to share-based payment awards 21 15
$ 2,419 $ 2,302 Net Earnings for basic and diluted EPS $ 6,995 $ 6,065
1,558 1,558 Weighted-average shares for basic EPS 1,558 1,557
2 — Plus Contingently Issuable Performance Stock Units 2 —
1,560 1,558 Weighted-average shares for diluted EPS 1,560 1,557
(2) Includes the impact of shares outstanding and share-based payments

-- 37 of 48 --

Schedule 2
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Reported Diluted EPS to Reported Diluted EPS, excluding Currency,
and Reconciliation of Reported Diluted EPS to Adjusted Diluted EPS, excluding Currency
(Unaudited)
Quarters Ended September 30, Nine Months Ended September 30,
2021 2020 % Change 2021 2020 % Change
$ 1.55 $ 1.48 4.7 % Reported Diluted EPS $ 4.48 $ 3.90 14.9 %
0.04 Less: Currency 0.18
$ 1.51 $ 1.48 2.0 % Reported Diluted EPS, excluding Currency $ 4.30 $ 3.90 10.3 %
Quarters Ended September 30, Nine Months Ended September 30, Year Ended
2021 2020 % Change 2021 2020 % Change 2020
$ 1.55 $ 1.48 4.7 % Reported Diluted EPS $ 4.48 $ 3.90 14.9 % $ 5.16
— — Saudi Arabia customs assessments 0.14 — —
0.02 — Asset impairment and exit costs 0.09 0.04 0.08
0.03 — Asset acquisition cost 0.03 — —
(0.02) — Equity investee ownership dilution (0.02) — —
— — Fair value adjustment for equity security investments — 0.04 0.04
— (0.06) Tax items — (0.06) (0.06)
— — Brazil indirect tax credit — — (0.05)
$ 1.58 $ 1.42 11.3 % Adjusted Diluted EPS $ 4.72 $ 3.92 20.4 % $ 5.17
0.04 Less: Currency 0.18
$ 1.54 $ 1.42 8.5 % Adjusted Diluted EPS, excluding Currency $ 4.54 $ 3.92 15.8 %

-- 38 of 48 --

Schedule 3
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Net Revenues by Product Category and Adjustments of Net Revenues for the Impact of Currency and Acquisitions
($ in millions) / (Unaudited)
Net
Revenues Currency
Net
Revenues
excluding
Currency
Acquisitions
Net
Revenues
excluding
Currency &
Acquisitions
Quarters Ended
September 30, Net
Revenues Total Excluding
Currency
Excluding
Currency &
Acquisitions
2021 Combustible Products 2020 % Change
$ 2,170 $ 88 $ 2,082 $ — $ 2,082 European Union $ 2,244 (3.3) % (7.2) % (7.2) %
635 (7) 641 — 641 Eastern Europe 636 (0.2) % 0.9 % 0.9 %
901 (28) 928 — 928 Middle East & Africa 768 17.3 % 20.8 % 20.8 %
1,061 6 1,055 — 1,055 South & Southeast Asia 1,071 (0.9) % (1.5) % (1.5) %
591 4 587 — 587 East Asia & Australia 605 (2.2) % (2.9) % (2.9) %
438 19 418 — 418 Americas 393 11.4 % 6.5 % 6.5 %
$ 5,796 $ 83 $ 5,713 $ — $ 5,713 Total Combustible $ 5,716 1.4 % (0.1) % (0.1) %
2021 Reduced-Risk Products 2020 % Change
$ 1,022 $ 40 $ 982 $ 2 $ 979 European Union $ 706 44.7 % 39.0 % 38.7 %
306 (6) 313 — 313 Eastern Europe 263 16.4 % 18.8 % 18.8 %
44 1 44 — 44 Middle East & Africa — — % — % — %
4 — 4 — 4 South & Southeast Asia — — % — % — %
932 (11) 943 — 943 East Asia & Australia 753 23.7 % 25.1 % 25.1 %
18 1 18 — 18 Americas 7 +100% +100% +100%
$ 2,326 $ 24 $ 2,302 $ 2 $ 2,300 Total RRPs $ 1,730 34.5 % 33.1 % 33.0 %
2021 PMI 2020 % Change
$ 3,192 $ 128 $ 3,064 $ 2 $ 3,062 European Union $ 2,950 8.2 % 3.9 % 3.8 %
941 (13) 954 — 954 Eastern Europe 899 4.7 % 6.1 % 6.1 %
945 (27) 972 — 972 Middle East & Africa 768 23.0 % 26.6 % 26.6 %
1,065 6 1,059 — 1,059 South & Southeast Asia 1,071 (0.6) % (1.1) % (1.1) %
1,523 (7) 1,530 — 1,530 East Asia & Australia 1,358 12.2 % 12.7 % 12.7 %
456 20 436 — 436 Americas 400 14.0 % 9.0 % 9.0 %
$ 8,122 $ 107 $ 8,015 $ 2 $ 8,013 Total PMI $ 7,446 9.1 % 7.6 % 7.6 %
Note: Sum of product categories or Regions might not foot to Total PMI due to roundings. "-" indicates amounts between -$0.5 million and +$0.5 million

-- 39 of 48 --

Schedule 4
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Net Revenues by Product Category and Adjustments of Net Revenues for the Impact of Currency and Acquisitions
($ in millions) / (Unaudited)
Net
Revenues Currency
Net
Revenues
excluding
Currency
Acquisitions
Net
Revenues
excluding
Currency &
Acquisitions
Nine Months Ended
September 30, Net
Revenues Total Excluding
Currency
Excluding
Currency &
Acquisitions
2021 Combustible Products 2020 % Change
$ 6,283 $ 445 $ 5,838 $ — $ 5,838 European Union $ 6,099 3.0 % (4.3) % (4.3) %
1,681 (29) 1,710 — 1,710 Eastern Europe 1,681 — % 1.7 % 1.7 %
2,208 (1) (67) 2,275 — 2,275 Middle East & Africa 2,296 (3.9) % (0.9) % (0.9) %
3,277 102 3,175 — 3,175 South & Southeast Asia 3,211 2.1 % (1.1) % (1.1) %
1,850 65 1,786 — 1,786 East Asia & Australia 1,876 (1.4) % (4.8) % (4.8) %
1,278 37 1,241 — 1,241 Americas 1,196 6.9 % 3.8 % 3.8 %
$ 16,577 $ 552 $ 16,025 $ — $ 16,025 Total Combustible $ 16,360 1.3 % (2.0) % (2.0) %
2021 Reduced-Risk Products 2020 % Change
$ 2,967 $ 206 $ 2,761 $ 2 $ 2,759 European Union $ 1,861 59.5 % 48.4 % 48.3 %
951 (45) 996 — 996 Eastern Europe 789 20.5 % 26.2 % 26.2 %
98 1 97 — 97 Middle East & Africa 52 90.2 % 87.7 % 87.7 %
7 — 7 — 7 South & Southeast Asia — — % — % — %
2,659 36 2,622 — 2,622 East Asia & Australia 2,169 22.6 % 20.9 % 20.9 %
42 1 41 — 41 Americas 20 +100% +100% +100%
$ 6,724 $ 200 $ 6,524 $ 2 $ 6,522 Total RRPs $ 4,890 37.5 % 33.4 % 33.4 %
2021 PMI 2020 % Change
$ 9,250 $ 651 $ 8,599 $ 2 $ 8,597 European Union $ 7,960 16.2 % 8.0 % 8.0 %
2,632 (74) 2,706 — 2,706 Eastern Europe 2,470 6.6 % 9.6 % 9.6 %
2,306 (1) (66) 2,372 — 2,372 Middle East & Africa 2,348 (1.8) % 1.0 % 1.0 %
3,284 102 3,182 — 3,182 South & Southeast Asia 3,211 2.3 % (0.9) % (0.9) %
4,509 101 4,408 — 4,408 East Asia & Australia 4,045 11.5 % 9.0 % 9.0 %
1,320 38 1,282 — 1,282 Americas 1,216 8.6 % 5.4 % 5.4 %
$ 23,301 $ 752 $ 22,549 $ 2 $ 22,547 Total PMI $ 21,250 9.7 % 6.1 % 6.1 %
(1) Includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessments
Note: Sum of product categories or Regions might not foot to Total PMI due to roundings. "-" indicates amounts between -$0.5 million and +$0.5 million

-- 40 of 48 --

Schedule 5
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Net Revenues to Adjusted Net Revenues, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
Net
Revenues Special
Items
Adjusted
Net
Revenues Currency
Adjusted
Net
Revenues
excluding
Currency
Acqui-
sitions
Adjusted
Net
Revenues
excluding
Currency
& Acqui-
sitions
Net
Revenues Special
Items
Adjusted
Net
Revenues Total Excluding
Currency
Excluding
Currency
& Acqui-
sitions
2021 Quarters Ended
September 30, 2020 % Change
$ 3,192 $ — $ 3,192 $ 128 $ 3,064 $ 2 $ 3,062 European Union $ 2,950 $ — $ 2,950 8.2 % 3.9 % 3.8 %
941 — 941 (13) 954 — 954 Eastern Europe 899 — 899 4.7 % 6.1 % 6.1 %
945 — 945 (27) 972 — 972 Middle East & Africa 768 — 768 23.0 % 26.6 % 26.6 %
1,065 — 1,065 6 1,059 — 1,059 South & Southeast
Asia 1,071 — 1,071 (0.6) % (1.1) % (1.1) %
1,523 — 1,523 (7) 1,530 — 1,530 East Asia & Australia 1,358 — 1,358 12.2 % 12.7 % 12.7 %
456 — 456 20 436 — 436 Americas 400 — 400 14.0 % 9.0 % 9.0 %
$ 8,122 $ — $ 8,122 $ 107 $ 8,015 $ 2 $ 8,013 Total PMI $ 7,446 $ — $ 7,446 9.1 % 7.6 % 7.6 %
2021 Nine Months Ended
September 30, 2020 % Change
$ 9,250 $ — $ 9,250 $ 651 $ 8,599 $ 2 $ 8,597 European Union $ 7,960 $ — $ 7,960 16.2 % 8.0 % 8.0 %
2,632 — 2,632 (74) 2,706 — 2,706 Eastern Europe 2,470 — 2,470 6.6 % 9.6 % 9.6 %
2,306 (246) (1) 2,552 (66) 2,618 — 2,618 Middle East & Africa 2,348 — 2,348 8.7 % 11.5 % 11.5 %
3,284 — 3,284 102 3,182 — 3,182 South & Southeast
Asia 3,211 — 3,211 2.3 % (0.9) % (0.9) %
4,509 — 4,509 101 4,408 — 4,408 East Asia & Australia 4,045 — 4,045 11.5 % 9.0 % 9.0 %
1,320 — 1,320 38 1,282 — 1,282 Americas 1,216 — 1,216 8.6 % 5.4 % 5.4 %
$ 23,301 $ (246) $ 23,547 $ 752 $ 22,795 $ 2 $ 22,793 Total PMI $ 21,250 $ — $ 21,250 10.8 % 7.3 % 7.3 %
(1) Represents the Saudi Arabia customs assessments

-- 41 of 48 --

Schedule 6
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Adjustments of Operating Income for the Impact of Currency and Acquisitions
($ in millions) / (Unaudited)
Operating
Income Currency
Operating
Income
excluding
Currency
Acquisitions
Operating
Income
excluding
Currency &
Acquisitions
Operating
Income Total Excluding
Currency
Excluding
Currency &
Acquisitions
2021 Quarters Ended
September 30, 2020 % Change
$ 1,680 (1) $ 79 $ 1,601 $ — $ 1,601 European Union $ 1,588 5.8 % 0.8 % 0.8 %
338 (1) 30 308 — 308 Eastern Europe 245 38.0 % 25.7 % 25.7 %
388 (1) (29) 417 — 417 Middle East & Africa 261 48.7 % 59.8 % 59.8 %
348 (1) 4 344 — 344 South & Southeast Asia 402 (13.4) % (14.4) % (14.4) %
631 (1) (23) 654 — 654 East Asia & Australia 637 (0.9) % 2.7 % 2.7 %
121 (1) 4 117 — 117 Americas 110 10.0 % 6.4 % 6.4 %
(51) (2) — (51) — (51) Other — — % — % — %
$ 3,455 $ 65 $ 3,390 $ — $ 3,390 Total PMI $ 3,243 6.5 % 4.5 % 4.5 %
2021 Nine Months Ended
September 30, 2020 % Change
$ 4,811 (3) $ 413 $ 4,398 $ — $ 4,398 European Union $ 3,924 (5) 22.6 % 12.1 % 12.1 %
913 (3) (2) 915 — 915 Eastern Europe 610 (5) 49.7 % 50.0 % 50.0 %
739 (4) (74) 813 — 813 Middle East & Africa 819 (5) (9.8) % (0.7) % (0.7) %
1,208 (3) 36 1,172 — 1,172 South & Southeast Asia 1,290 (5) (6.4) % (9.1) % (9.1) %
2,041 (3) (6) 2,047 — 2,047 East Asia & Australia 1,792 (5) 13.9 % 14.2 % 14.2 %
367 (3) 12 355 — 355 Americas 328 (5) 11.9 % 8.2 % 8.2 %
(51) (2) — (51) — (51) Other — — % — % — %
$ 10,028 $ 379 $ 9,649 $ — $ 9,649 Total PMI $ 8,763 14.4 % 10.1 % 10.1 %
(1) Includes asset impairment and exit costs: EU ($12 million), EE ($2 million), ME&A ($3 million), S&SA ($4 million), EA&A ($21 million) and AMCS ($1 million)
(2) Includes asset acquisition cost ($51 million) related to OtiTopic Inc. in August 2021
(3) Includes asset impairment and exit costs: EU ($56 million), EE ($11 million), S&SA ($17 million), EA&A ($67 million) and AMCS ($6 million)
(4) Includes the Saudi Arabia customs assessments ($246 million) and asset impairment and exit costs ($13 million)
(5) Includes asset impairment and exit costs: EU ($27 million), EE ($7 million), ME&A ($9 million), S&SA ($11 million), EA&A ($13 million) and AMCS ($4 million)

-- 42 of 48 --

Schedule 7
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Operating Income to Adjusted Operating Income, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
Operating
Income
Asset
Impairment
& Exit Costs
and Others
Adjusted
Operating
Income Currency
Adjusted
Operating
Income
excluding
Currency
Acqui-
sitions
Adjusted
Operating
Income
excluding
Currency
& Acqui-
sitions
Operating
Income
Asset
Impairment
& Exit Costs
Adjusted
Operating
Income Total Excluding
Currency
Excluding
Currency
& Acqui-
sitions
2021 Quarters Ended
September 30, 2020 % Change
$ 1,680 $ (12) (1) $ 1,692 $ 79 $ 1,613 $ — $ 1,613 European Union $ 1,588 $ — $ 1,588 6.5 % 1.6 % 1.6 %
338 (2) (1) 340 30 310 — 310 Eastern Europe 245 — 245 38.8 % 26.5 % 26.5 %
388 (3) (1) 391 (29) 420 — 420 Middle East & Africa 261 — 261 49.8 % 60.9 % 60.9 %
348 (4) (1)
352 4 348 — 348 South & Southeast
Asia 402 — 402 (12.4) % (13.4) % (13.4) %
631 (21) (1) 652 (23) 675 — 675 East Asia & Australia 637 — 637 2.4 % 6.0 % 6.0 %
121 (1) (1) 122 4 118 — 118 Americas 110 — 110 10.9 % 7.3 % 7.3 %
(51) (51) (2) — — — — — Other — — — — % — % — %
$ 3,455 $ (94) $ 3,549 $ 65 $ 3,484 $ — $ 3,484 Total PMI $ 3,243 $ — $ 3,243 9.4 % 7.4 % 7.4 %
2021 Nine Months Ended
September 30, 2020 % Change
$ 4,811 $ (56) (1) $ 4,867 $ 413 $ 4,454 $ — $ 4,454 European Union $ 3,924 $ (27) (1) $ 3,951 23.2 % 12.7 % 12.7 %
913 (11) (1) 924 (2) 926 — 926 Eastern Europe 610 (7) (1) 617 49.8 % 50.1 % 50.1 %
739 (259) (3) 998 (74) 1,072 — 1,072 Middle East & Africa 819 (9) (1) 828 20.5 % 29.5 % 29.5 %
1,208 (17) (1)
1,225 36 1,189 — 1,189 South & Southeast
Asia 1,290 (11) (1)
1,301 (5.8) % (8.6) % (8.6) %
2,041 (67) (1) 2,108 (6) 2,114 — 2,114 East Asia & Australia 1,792 (13) (1) 1,805 16.8 % 17.1 % 17.1 %
367 (6) (1) 373 12 361 — 361 Americas 328 (4) (1) 332 12.3 % 8.7 % 8.7 %
(51) (51) (2) — — — — — Other — — — — % — % — %
$ 10,028 $ (467) $ 10,495 $ 379 $ 10,116 $ — $ 10,116 Total PMI $ 8,763 $ (71) $ 8,834 18.8 % 14.5 % 14.5 %
(1) Represents asset impairment and exit costs
(2) Represents asset acquisition cost related to OtiTopic Inc. in August 2021
(3) Includes the Saudi Arabia customs assessments ($246 million) and asset impairment and exit costs ($13 million)

-- 43 of 48 --

Schedule 8
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Adjusted Operating Income Margin, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
Adjusted
Operating
Income
(1)
Adjusted
Net
Revenues
(2)
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
excluding
Currency
(1)
Adjusted
Net
Revenues
excluding
Currency
(2)
Adjusted
Operating
Income
Margin
excluding
Currency
Adjusted
Operating
Income
excluding
Currency
& Acqui-
sitions (1)
Adjusted
Net
Revenues
excluding
Currency
& Acqui-
sitions (2)
Adjusted
Operating
Income
Margin
excluding
Currency
& Acqui-
sitions
Adjusted
Operating
Income
(1)
Adjusted
Net
Revenues
(2)
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
Margin
excluding
Currency
Adjusted
Operating
Income
Margin
excluding
Currency
& Acqui-
sitions
2021 Quarters Ended
September 30, 2020 % Points Change
$ 1,692 $ 3,192 53.0 % $ 1,613 $ 3,064 52.6 % $ 1,613 $ 3,062 52.7 % European Union $ 1,588 $ 2,950 53.8 % (0.8) (1.2) (1.1)
340 941 36.1 % 310 954 32.5 % 310 954 32.5 % Eastern Europe 245 899 27.3 % 8.8 5.2 5.2
391 945 41.4 % 420 972 43.2 % 420 972 43.2 % Middle East & Africa 261 768 34.0 % 7.4 9.2 9.2
352 1,065 33.1 % 348 1,059 32.9 % 348 1,059 32.9 % South & Southeast Asia 402 1,071 37.5 % (4.4) (4.6) (4.6)
652 1,523 42.8 % 675 1,530 44.1 % 675 1,530 44.1 % East Asia & Australia 637 1,358 46.9 % (4.1) (2.8) (2.8)
122 456 26.8 % 118 436 27.1 % 118 436 27.1 % Americas 110 400 27.5 % (0.7) (0.4) (0.4)
$ 3,549 $ 8,122 43.7 % $ 3,484 $ 8,015 43.5 % $ 3,484 $ 8,013 43.5 % Total PMI $ 3,243 $ 7,446 43.6 % 0.1 (0.1) (0.1)
2021 Nine Months Ended
September 30, 2020 % Points Change
$ 4,867 $ 9,250 52.6 % $ 4,454 $ 8,599 51.8 % $ 4,454 $ 8,597 51.8 % European Union $ 3,951 $ 7,960 49.6 % 3.0 2.2 2.2
924 2,632 35.1 % 926 2,706 34.2 % 926 2,706 34.2 % Eastern Europe 617 2,470 25.0 % 10.1 9.2 9.2
998 2,552 39.1 % 1,072 2,618 40.9 % 1,072 2,618 40.9 % Middle East & Africa 828 2,348 35.3 % 3.8 5.6 5.6
1,225 3,284 37.3 % 1,189 3,182 37.4 % 1,189 3,182 37.4 % South & Southeast Asia 1,301 3,211 40.5 % (3.2) (3.1) (3.1)
2,108 4,509 46.8 % 2,114 4,408 48.0 % 2,114 4,408 48.0 % East Asia & Australia 1,805 4,045 44.6 % 2.2 3.4 3.4
373 1,320 28.3 % 361 1,282 28.2 % 361 1,282 28.2 % Americas 332 1,216 27.3 % 1.0 0.9 0.9
$ 10,495 $ 23,547 44.6 % $ 10,116 $ 22,795 44.4 % $ 10,116 $ 22,793 44.4 % Total PMI $ 8,834 $ 21,250 41.6 % 3.0 2.8 2.8
(1) For the calculation of Adjusted Operating Income and Adjusted Operating Income excluding currency and acquisitions refer to Schedule 7
(2) For the calculation of Adjusted Net Revenues excluding currency and acquisitions refer to Schedule 5

-- 44 of 48 --

Schedule 9
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Condensed Statements of Earnings
($ in millions, except per share data) / (Unaudited)
Quarters Ended September 30, Nine Months Ended September 30,
2021 2020 Change
Fav./(Unfav.) 2021 2020 Change
Fav./(Unfav.)
$ 21,617 $ 20,444 5.7 % Revenues including Excise Taxes (1) $ 61,393 $ 56,516 8.6 %
13,495 12,998 (3.8) % Excise Taxes on products 38,092 35,266 (8.0) %
8,122 7,446 9.1 % Net Revenues (1) 23,301 21,250 9.7 %
2,596 2,416 (7.5) % Cost of sales 7,223 6,997 (3.2) %
5,526 5,030 9.9 % Gross profit 16,078 14,253 12.8 %
2,053 1,769 (16.1) % Marketing, administration and research costs (2) 5,995 5,435 (10.3) %
18 18 Amortization of intangibles 55 55
3,455 3,243 6.5 % Operating Income 10,028 8,763 14.4 %
154 163 5.5 % Interest expense, net 482 454 (6.2) %
27 23 (17.4) % Pension and other employee benefit costs 82 68 (20.6) %
3,274 3,057 7.1 % Earnings before income taxes 9,464 8,241 14.8 %
735 640 (14.8) % Provision for income taxes 2,078 1,764 (17.8) %
(49) (20) Equity investments and securities (income)/loss, net (95) 4
2,588 2,437 6.2 % Net Earnings 7,481 6,473 15.6 %
162 130 Net Earnings attributable to noncontrolling interests 465 393
$ 2,426 $ 2,307 5.2 % Net Earnings attributable to PMI $ 7,016 $ 6,080 15.4 %
Per share data (3):
$ 1.55 $ 1.48 4.7 % Basic Earnings Per Share $ 4.49 $ 3.90 15.1 %
$ 1.55 $ 1.48 4.7 % Diluted Earnings Per Share $ 4.48 $ 3.90 14.9 %
(1) Nine months ended September 30, 2021 includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessments
(2) Quarter ended September 30, 2021 includes asset acquisition cost ($51 million) related to OtiTopic Inc. in August 2021 and asset impairment and exit costs ($43 million). Nine months ended September 30, 2021
includes asset acquisition cost ($51 million) and asset impairment and exit costs ($170 million). Nine months ended September 30, 2020 includes asset impairment and exit costs ($71 million)
(3) Net Earnings and weighted-average shares used in the basic and diluted Earnings Per Share computations for the quarters and for the nine months ended September 30, 2021 and 2020 are shown on Schedule
1, Footnote 1

-- 45 of 48 --

Schedule 10
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Condensed Balance Sheets
($ in millions) / (Unaudited)
September 30, December 31,
2021 2020
Assets
Cash and cash equivalents $ 4,491 $ 7,280
All other current assets 13,355 14,212
Property, plant and equipment, net 6,061 6,365
Goodwill 6,814 5,964
Other intangible assets, net 2,893 2,019
Equity investments 4,624 4,798
Other assets 3,351 4,177
Total assets $ 41,589 $ 44,815
Liabilities and Stockholders' (Deficit) Equity
Short-term borrowings $ 223 $ 244
Current portion of long-term debt 3,114 3,124
All other current liabilities 14,540 16,247
Long-term debt 25,768 28,168
Deferred income taxes 720 684
Other long-term liabilities 5,856 6,979
Total liabilities 50,221 55,446
Total PMI stockholders' deficit (10,551) (12,567)
Noncontrolling interests 1,919 1,936
Total stockholders' (deficit) equity (8,632) (10,631)
Total liabilities and stockholders' (deficit) equity $ 41,589 $ 44,815

-- 46 of 48 --

Schedule 11
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Calculation of Total Debt to Adjusted EBITDA and Net Debt to Adjusted EBITDA Ratios
($ in millions, except ratios) / (Unaudited)
Year Ended September 30, 2021
Year Ended
December 31,
2020
October ~
December January ~
September 12 months
2020 2021 rolling
Net Earnings $ 2,119 $ 7,481 $ 9,600 $ 8,592
Equity investments and securities (income)/loss, net (20) (95) (115) (16)
Provision for income taxes 613 2,078 2,691 2,377
Interest expense, net 164 482 646 618
Depreciation and amortization 272 719 991 981
Asset impairment and exit costs and Others (1) (41) 467 426 30
Adjusted EBITDA $ 3,107 $ 11,132 $ 14,239 $ 12,582
September 30, December 31,
2021 2020
Short-term borrowings $ 223 $ 244
Current portion of long-term debt 3,114 3,124
Long-term debt 25,768 28,168
Total Debt $ 29,105 $ 31,536
Cash and cash equivalents 4,491 7,280
Net Debt $ 24,614 $ 24,256
Ratios:
Total Debt to Adjusted EBITDA 2.04 2.51
Net Debt to Adjusted EBITDA 1.73 1.93
(1) For the period January 2021 to September 2021 "Others" includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessments that was recorded in the
second quarter of 2021 and asset acquisition cost of $51 million related to OtiTopic Inc. in August 2021. For the period October 2020 to December 2020 and for the year ended December 31,
2020, "Others" include the Brazil indirect tax credit $119 million that was recorded in the fourth quarter of 2020.

-- 47 of 48 --

Schedule 12
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Operating Cash Flow to Operating Cash Flow, excluding Currency
($ in millions) / (Unaudited)
Quarters Ended September 30, Nine Months Ended September 30,
2021 2020 % Change 2021 2020 % Change
$ 3,870 $ 3,614 7.1 % Net cash provided by operating activities (1) $ 7,935 $ 6,650 19.3 %
140 Less: Currency 759
$ 3,730 $ 3,614 3.2 % Net cash provided by operating activities,
excluding currency $ 7,176 $ 6,650 7.9 %
(1) Operating cash flow

-- 48 of 48 --